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TENDON EXTRACELLULAR MATRIX: TENOGENIC ACTIVITY ON 
MESENCHYMAL STEM CELLS AND UTILITY IN TENDON TISSUE ENGINEERING 
Guang Yang, Ph.D. 
University of Pittsburgh, 2015 
Because of the limited and unsatisfactory outcomes of clinical tendon repair, tissue 
engineering approaches using adult mesenchymal stem cells (MSCs) are being considered a 
promising alternative healing strategy for injured tendon tissues. Successful and functional 
tendon tissue engineering depends on harnessing the biochemical cues presented by the native 
tendon extracellular matrix (ECM) and the embedded tissue-specific bio-factors. We have 
prepared and characterized the biological activities of a soluble extract of decellularized tendon 
ECM (tECM) on adult adipose derived stem cells (ASCs) on the basis of histological, 
biochemical, and gene expression analyses. Our results revealed the tenogenic effect of tECM on 
hASCs cultured in a 3-dimensional (3D) collagen scaffold under uniaxial tension. The presence 
of tECM also suppressed the osteogenic differentiation of hASCs induced by uniaxial tension 
and enhanced scaffold mechanical strength, accompanied by reduced expression and activity of 
matrix metalloproteinases (MMPs). Furthermore, we found that tECM enhanced the proliferation 
and TGF-β3 induced tenogenesis of ASCs, and modulated matrix deposition and organization by 
ASCs seeded in 3D fibrous scaffolds. These findings support the utility of tECM in creating bio-
functional scaffolds for tendon tissue engineering. We also report here the development of a 
novel composite fibrous scaffold as a tendon graft fabricated by co-electrospinning of poly-ε-
v 
caprolactone (PCL) and methacrylated gelatin (mGLT), which allowed the encapsulation of 
ASCs within the scaffold upon visible light induced gelatin photo-crosslinking, as well as the 
formation of stable, crosslinked multi-layered constructs. This scaffold design may improve cell-
based tendon regeneration by serving as an effective reservoir of tECM and tenogenic growth 
factors to recapitulate the structural and biochemical characteristics of native tendon tissue. Our 
findings should lead to translational tissue engineering applications that will improve patient 
outcomes in the context of clinical tendon repair. 
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1.0 INTRODUCTION 
This chapter includes materials excerpted from the following publication: 
Guang Yang, Benjamin B. Rothrauff, and Rocky S. Tuan. Tendon and Ligament 
Regeneration and Repair: Clinical Relevance and Developmental Paradigm. Birth Defects Res C 
Embryo Today. 2013 Sep; 99(3): 203–222. doi: 10.1002/bdrc.21041 
1.1 TENDON BIOLOGY 
1.1.1 Development of tendon tissues 
Tendons are fibrous tissues composed of densely packed collagen fiber bundles that 
connect muscle to bone, and function in force transmission from muscle to bone. Tendon 
development has been intensively studied in multiple animal models, and was historically 
divided into two domains of the developing embryos—(1) tendons of the limb, and (2) tendons 
of the axial skeleton and abdomen. Early studies on limb tendons revealed that distal limb 
tendons appear to first arise from the lateral plate mesoderm and consist of a single dorsal and 
ventral blastema. With the progress of development, the dorsal blastema differentiates into the 
extensor tendons of each phalange, while the ventral blastema splits to form the flexor tendons of 
the digits [1, 2]. Although eventually connected to muscle tissues, distal tendon primordia can 
2 
segregate into individual tendons in a normal temporal and spatial pattern in the absence of limb 
muscles. In contrast, the proximal tendon blastema must develop in close proximity to muscle 
precursors [3]. 
A number of tendon-specific genes dynamically coordinate to give rise to an ultimate 
specification of tendon tissues. For instance, the murine homeobox-containing genes Six 1 and 
Six 2 are involved in the patterning of mouse dorsal extensor and ventral flexor tendons of the 
phalangeal elements in a complementary manner [4]. Likewise, Eya1 and Eya2, two mouse 
homologs of Drosophila eyes absent (Eya) gene, are associated with cell condensations that form 
limb tendons and may as well function along with Six to pattern dorsal and ventral limb tendon 
morphogenesis [2]. Follistatin and Eph-A4 are expressed in tendon-forming regions of 
developing chick limbs to coordinate cartilage and tendon development [5]. 
In the past decade, the identification of several new gene markers that are selectively 
associated with early tendon primordial and mature tendon has enabled tracking of the origin and 
formation of tendon progenitor cells. Most notably, scleraxis (SCX), a basic helix-loop-helix 
transcription factor originally found in all muscle-to-bone attachment sites in chick embryos, is 
used as a marker to identify tendon cell fate [6, 7]. Expressed from Hamburger-Hamilton (HH) 
stage 21 onward, SCX expression in the limb bud reveals the superficial proximomedial limb 
mesenchyme as the origin site of limb tendon formation. Signals from the ectoderm are 
necessary for the induction and proliferation of the SCX-expressing tendon cells, although no 
direct ectodermal interference with SCX expression exists. Conversely, bone morphogenetic 
protein (BMP) secreted from surrounding areas suppress SCX-expression to restrict the location 
and scale of tendon cell phenotype adoption. At later stages, the repressive effects of BMP 
signaling are partially blocked by the BMP antagonist Noggin (Fig. 1) [7]. 
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Figure 1. Factors involved in limb tendon development and their spatial distribution with respect to 
proximal–distal axis. Scleraxis (SCX), Mohawk (MKX), and TGF-β are functional in the formation of most limb 
tendons. Morphogenesis of proximal tendon is coupled with muscle precursors. Genes including Six1/2, Eya1/2, and 
Follistatin are expressed in distal regions and are thought to pattern flexor and extensor tendon morphogenesis, 
whereas Eph-A4 transcripts are localized in a more proximal region and later in the body of the tendon. 
 
Unlike limb tendons, somite is the origin of the tendons that attach the back muscles to 
the vertebrae, and the intercostal muscles to the ribs [8]. Through tracking SCX expression, axial 
and trunk tendon progenitor cells were found to constitute a previously undetected fourth somitic 
compartment, the “syndetome” (Fig. 2), that derives from the early sclerotome [9]. SCX-
expressing progenitor cell population lies between adjacent myotomes, both dorsomedial and 
ventrolateral to sclerotome [9]. SCX null mutant mice (SCX−/−) displayed severe tendon loss 
and defects, reflected by limited use of paws and tail. The residual tendons that persisted in 
SCX−/− mutants showed disrupted compartmentalization of differentiated tendon cells, known 
as tenocytes (TCs), and endotenon cells due to less-organized tendon matrix. Interestingly, 
unlike disrupted force-transmitting and intermuscular tendons, other categories of tendons were 
less affected or fully functional in SCX−/− mutants [10]. Such variety of tendon phenotype 
exemplifies the diversity of tendon tissue origin and the complexity of tendon development.  
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Figure 2. Somite structure depicted in transverse section. Scleraxis (SCX)-expressing cells (purple) are 
found between the sclerotome and myotome and constitute a fourth somitic compartment, syndetome. 
 
In addition to attempts in understanding the origin and identity of tendon progenitor cells, 
considerable efforts have been made to elucidate the instructive cues of these cells. Notably, 
SCX expression is initiated later than markers of other somitic compartments, [10] such temporal 
pattern implies the involvement of signals from other compartments in tendon morphogenesis. 
For instance, fibroblast growth factor (FGF) secreted from the myotome was necessary and 
sufficient for SCX induction through the activation of Ets transcription factors polyomavirus 
enhancer activator 3 (PEA3) and Ets-related molecule (ERM) [2]. The induction of SCX 
expression is also dependent on signals from the sclerotome. In fact, although tendon progenitor 
cells and cartilage progenitor cells initially overlap in dorsolateral sclerotome domains, their 
distribution becomes distinct with the progress of differentiation. Cells constituting the axial 
tendon and cartilage are exclusive lineages: cartilage differentiation represses tendon 
development in the dorsolateral sclerotome [11]. Ventral midline expression of sonic hedgehog 
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(SHH) might also be involved in SCX expression, for mis-expression of SHH led to loss of SCX 
[11]. In addition to FGF and SHH, several members of the transforming growth factor-β (TGF-β) 
superfamily are identified in the tenogenesis cascade. For instance, in the chick embryo, TGF-
β2/3 ligands and their receptors were detected in mid-substance and endotenon of tertiary 
bundles during the intermediate stages of tendon development [12]. Likewise, murine patellar 
tendon cells were found to be responsive to TGF-β and BMP signaling at all stages examined 
starting at E17.5 and ending at P14 [13]. The in vivo involvement of TGF-β signaling in 
tenogenesis was confirmed in a mouse model in which the disruption of TGF-β signaling 
resulted in the loss of most tendons and ligaments [14]. Equally important, TGF-β signaling 
coordinates cartilage and tendon differentiation in the developing limb mesenchyme [15]: TGF-
β1 or TGF-β2 treatment on microssmass culture of primary chicken mesenchymal cells 
transformed prechondrogenic aggregates into fibrous tendon tissue through activation of 
tenogenic gene SCX and inhibition of chondrogenic genes SOX9. 
In addition to SCX, two other putative markers attracting growing research attention are 
tenomodulin (TNMD), and mohawk homeobox (MKX). TNMD encodes a type II 
transmembrane glycoprotein that contains a C-terminal anti-angiogenic domain and is 
dominantly expressed in tendons and ligaments. Overexpression of SCX caused significant 
increase in TNMD level of cultured TCs but not chondrocytes, indicating that the impact of SCX 
on TNMD is restricted to the tendon lineage [16]. Unlike TNMD, MKX might act as the 
upstream regulator of SCX, for overexpression of MKX led to higher SCX expression through 
activation of the TGF-β signaling [17]. However, on the other hand, no obvious change was 
found in the level or spatiotemporal pattern of SCX expression in MKX-/- mutants compared to 
wild-type embryos (Fig. 3) [18].  
6 
Figure 3. Summary of genes involved in regulating scleraxis (SCX) expression in somites and the 
subsequent mediators of collagen expression in tendons. 
While a complex signaling network of tendon differentiation begins to emerge, a key to 
successful adult tendon regeneration through recapitulation of developmental events is to 
understand the functions of the molecular markers in shaping the biochemical/physical feature of 
tendons. For instance, the transcription factors SCX and NFATc4 coordinate to activate the gene 
encoding α1 chain of collagen type I (COL I A1) in tendon fibroblasts through binding to two 
short tendon-specific elements: TSE1 and TSE2. Conversely, inhibition of the nuclear 
translocation of NFATc proteins inhibited the expression of collagen type I (COL I) [19]. MKX 
is another possible regulator of collagen production in TCs as a transcriptional repressor [17]. 
MKX−/− mice exhibited smaller tendons and disrupted tendon collagen fibrils with significantly 
reduced amounts of COL I, fibromodulin, and TNMD compared with wild-type animals. Lastly, 
recent research has partially revealed the role of TNMD in tendon collagen organization: The 
variation in collagen fibrils diameter was significantly higher in TNMD deficient mice. Loss of 
TNMD expression also led to reduced TC density and proliferation rate [20].  
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1.1.2 The structure and composition of tendon tissue 
Fibrillar collagens, including types I, II, III, V, and XI, constitute the basic structural 
framework of tendons and ligaments [21]. Synthesis and deposition of these collagenous fibrils 
was initiated in both longitudinal and lateral directions by tendon progenitors during the embryo 
stage and continues after birth [22]. Gradual decrease in the cell-to-matrix ratio occurs along 
with maturation and aging, and collagen ultimately accounts for 65–80% of the dry mass of 
tendon tissue [23]. Fibrillar collagen molecules consist of three α chains that are wrapped around 
one other to form a triple stranded helical rod. Each α chain is arranged in the repeating structure 
Gly-X-Y, in which X and Y are frequently proline and hydroxyproline, respectively [24]. 
Glycine allows the three helical α chains to pack tightly due to the absence of side chain, 
meanwhile the conformation of helix is stabilized by the ring structure of proline (Fig. 4). 
Synthesis of the mature collagen protein is a multiple-step process. Intracellularly formed 
alpha chains are assembled into triple helix molecules as procollagen molecules that have 
additional propeptide domains at the COOH- and NH2-terminal ends of each chain. The 
propeptide domains solubilize procollagen molecules and thereby prevent intracellular assembly 
and precipitation. After partial hydroxylation and glycosylation of the proline and lysine 
residues, procollagen molecules are transported to cell surface and secreted into the extracellular 
space, where the propeptide domains are removed by specific telopeptidase cleavage to form 
less-soluble tropocollagen. Modified tropocollagen molecules self-assemble into fibrils that have 
periodic cross-striation every 67 nm, reflecting the staggered packing of individual collagen 
molecules in each fibril. Collagen fibrils are often 100 to 500-nm in diameter, and further 
bundled into fibers between which tenocytes (TCs) reside and maintain the extracellular matrix 
(ECM) (Fig. 4) [23]. The number and diameter of collagen fibers in tendon tissues are highly 
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variable among sites and species. Geometrically speaking, while most fibers are aligned 
longitudinally along tendon tissue, collagen fibers may also be oriented transversely. The 
heterogeneity in fiber orientation allows tendon to resist forces from various directions, although 
principally functioning in uniaxial tension [25]. 
 
 
Figure 4. The hierarchical structure of collagen fibers. (A) Single collagen α chain is arranged as a helix 
with three amino acids per turn. (B) Collagen molecule consists of three α chains coiled to form a triple-stranded 
helix. (C and D) Collagen molecules self-assemble into quarter-staggered, periodic striated fibrils every 67 nm. (E) 
A group of collagen fibrils further bundle to form a collagen fiber. 
 
In native tendon tissues, a group of collagen fibers are wrapped by a layer of connective 
tissue known as endotenon that contains blood vessels, lymphatics, and nerves, to form fascicles.  
Yet another connective tissue layer, the epitenon, surrounds fascicles to outline the tendon tissue. 
Some types of tendons are further surrounded by smooth surface connective tissue called 
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paratenon that functions as an elastic sleeve to allow free movement of the tendon against the 
surrounding tissues (Fig. 5) [26]. Collagen type I protein (Col I) is the dominant fibril-forming 
collagen in tendons as a heterotrimer consisting of two α1 chains and one α2 chain. Col I 
copolymerizes with collagen type V [27], as well as other nonfibrillar collagens to regulate the 
fibrillogenesis during tendon development. These collagens include the fibril-associated 
collagens with interrupted triple helices (FACIT) such as collagen types XII and XIV [22, 28].  
 
Figure 5. The hierarchical architecture of tendon tissue. Collagen triple-helices self-assemble into fibrils. 
Bundles of fibrils form fibers constitute tendon fascicles. Tendon fibroblasts (tenocytes, TCs) reside between 
collagen fibers. Fascicles are wrapped by endotenon, a layer of connective tissue containing blood vessels, nerves, 
and lymphatics. Multiple fascicles are further surrounded by another connective tissue layer, epitenon, to form the 
tendon tissue. 
 
Non-collagenous ECM proteins such as glycoproteins, proteoglycans, and elastic fibers 
are of great importance in maintaining TC phenotype and tissue homeostasis, despite relatively 
low abundance compared to collagen [25]. Proteoglycans are the most abundant class of 
glycoproteins within tendon, consisting of a core protein and at least one glycosaminoglycan 
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(GAG) as polysaccharide chain. Small leucine rich proteoglycan (SLRP) is the major type of 
tendon proteoglycans, including decorin, biglycan, fibromodulin, and lumican. SLRPs are able to 
facilitate fibril assembly and ultrastructural organization of the tendon through binding non-
covalently to the gap region of collagen fibrils at specific sites [29]. Table 1 summarizes the 
function of major non-collagenous proteins found in tendon tissue.  
As the development and growth proceeds, tendon tissue stiffens due to accumulating 
collagen deposition and structural arrangement alteration. Proper formation of covalent cross-
links occurs at the overlapping ends of adjacent collagen molecules during maturation to enhance 
collagen interconnectivity and fibril stability, primarily driven by the lysyl oxidase that acts on 
specific lysine and hydroxylysine residues [30-32]. Equally important, SLRPs have been 
proposed to stabilize the collagen network by either functioning as aforementioned crosslinkers 
between adjacent collagen fibrils (Table 1); or via regulating lysyl oxidase-mediated cross-link 
formation. For example, when binding to collagen, fibromodulin sterically hinders the access of 
lysyl oxidase to telopeptides [33]. Beyond activity in cross-link formations, hydroxyproline also 
contributes to the strength of fibrils by forming hydrogen bonds between polypeptide chains 
between tropocollagen molecules. Nevertheless, in spite of increasing knowledge in biochemical 
composition and mutual interaction between components of tendon tissue, the structure–function 








Table 1. Non-collagenous proteins in tendon tissue 
ECM protein Category Function Animal Study 
decorin (DCR) SLRP 
Interacts with the side chain of an 
adjacent DCR molecule to form 
interfibrillar bridge between 
adjacent collagen fibrils [35] 
DCR-deficient mice developed structurally 
impaired tendons with abnormal, irregular 
fibril contours and altered distribution of 
collagen fibril diameters [36]. 
biglycan 
(BGC) 
SLRP Binds to gap regions between 
sequential collagen fibrils; may 
compensate for decorin loss [36, 
37]; maintains the niche of TSPC 
[38].   
BGC-deficient mice exhibited disorganized 
collagen fibrils with irregular cross-
sectional profiles, increased prevalence of 
torn cruciate ligaments, and ectopic 
ossification in their patella tendon [37]. 
fibromodulin 
(FMOD) 
SLRP Stabilizes small-diameter fibrils 
due to the ability to inhibit fibril 
fusion [39] ; maintains the niche 
of TSPC [38]. 
FMOD deficiency led to reduced tendon 
stiffness, with further stiffness loss when 
combined with LMC knock out. FMOD and 
LMC may coordinate in a temporal order: 
FMOD is involved in early tendon 
development and LMC later stages [39]. lumican 
(LMC) 
SLRP Stabilizes small-diameter fibrils 




glycoprotein Presents binding sites for 
integrins, collagen, and other 
ECM proteins, as well as for self-
association [21]. 
FNC affects collagen type III fibril 
assembly and act as a template for neo-
collagen formation during the remodeling 





glycoprotein Interacts with free collagen types 
I and II molecules, bringing 
several molecules into close 
proximity so that these assemblies 
can further aggregate [40]. 
The distribution of collagen fibril diameters 
of tendons and ligaments in COMP−/− mice 
shifted toward larger median, with the 




glycoprotein Unclear, directly regulated by 
mechanical stress; induction of its 
expression in stretched fibroblasts 
is rapid [42]. 
High levels of TNC expression have been 
found in both developing and diseased 
tendons. TNC deposition is highest in 
tissues of high mechanical loading [43]. 
elastin fibrous 
protein 
May contribute to the resiliency 
and elasticity of tendon by 
promoting the recovery of the 
wavy collagen configuration after 
tendon stretch [29]. 
Elastin is known to situate between fascicles 
in the canine cruciate ligament. Rat tail 
tendon fascicles are surrounded by a thin 
sheath of elastin [44, 45]. 
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1.1.3 Tendon injury and natural healing 
Tendon injuries can be broadly categorized into chronic degenerative tendinopathies and 
acute ruptures. Degenerative tendinopathy is often followed by acute ruptures, with the former 
characterized by hypervascularity, mucoid degeneration, ectopic bone and cartilage nodules, and 
disorganized extracellular matrix [46]. The natural healing process of an injured tendon tissue is 
traditionally divided into three overlapping stages – (1) inflammation, (2) proliferation/repair, 
and (3) remodeling [47].  
In the inflammatory stage, blood clots forms immediately following rupture of tendon 
blood vessels to activate the release of chemo-attractants and serve as a provisional scaffold for 
invading cells. Inflammatory cells such as neutrophils, monocytes, and lymphocytes migrate 
from surrounding tissues into the wound site [48], along with the recruitment and activation of 
TCs until peaks in the subsequent stage known as the proliferative or reparative phase. Roughly 
two days after the occurrence of injury, fibroblasts from paratenon or surrounding synovial 
sheath are recruited to the wounded area and proliferate [49]. Meanwhile, intrinsic TCs residing 
in the endotenon and epitenon migrate to the wound site and begin to proliferate. TCs from both 
origins are involved in the synthesis of extracellular matrix and establishment of an internal 
neovascular network [50]. Concurrently, macrophages continue to release growth factors that 
direct cell recruitment and activity with a declining level of neutrophils. In this stage of healing, 
the matrix synthesized by TCs is rich in increased amount of collagen type III, water and 
glycosaminoglycan [51]. Lastly, the remodeling phase begins 1–2 months after injury, in which 
TCs and collagen fibers become aligned in the direction of tension. A higher proportion of 
collagen type I is found concomitant with decrease in cellularity, collagen type III and 
glycosaminoglycan contents [52, 53]. 10 weeks post-injury, the transformation of fibrous tissue 
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into scar-like tissue commences and continues for years. It should be remembered that repaired 
tissue never completely restores the mechanical strength it originally possessed before injury and 
the biochemical and structural characteristics remain abnormal for over one year [54]. 
Numerous bioactive molecules are involved in orchestrating tissue regeneration during 
tendon healing. A variety of growth factors are markedly upregulated following tendon injury 
and are active at multiple stages of the healing process, including insulin-like growth factor-I 
(IGF-I), transforming growth factor β (TGF-β), basic fibroblast growth factor (bFGF), platelet-
derived growth factor (PDGF), vascular endothelial growth factor (VEGF), bone morphogenetic 
protein (BMP), and connective tissue growth factor (CTGF) (Table 2). 
In addition to the spatial and temporal coordination of growth factors in tendon healing, 
several other families of bioactive molecules have been recently identified as mediators of repair. 
For instance, matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) are known to 
respond to tendon injury and repair [55, 56]: MMP-9 and MMP-13 participated in collagen 
degradation in rat flexor tendon laceration while MMP-2, MMP-3, and MMP-14 mediated both 
collagen degradation and remodeling. Likewise, markers of re-innervation such as growth 
associated protein 43 (GAP-43) and protein gene product 9.5 (PGP9.5), were found active during 
tendon healing [57]. Lastly, nitric oxide appears to be involved in tendon healing. Nitric oxide 
synthase (NOS) levels elevated following Achilles tendon tenotomy in a rat model, while 
inhibition of NOS reduced the cross-sectional area and the failure load of healing tendons [58]. 
The increasing understanding of the molecular basis of tendon healing has led to improved 





Table 2. Bioactive molecules involved in natural tendon healing process [59, 60] 
Growth factor  Roles Animal study 
insulin-like growth 
factor-I (IGF-I) 
Promotes the proliferation and 
migration of cells, stimulates matrix 
production 
IGF-I mRNA levels were significantly higher 3 weeks 
after injury to rabbit medial collateral ligament [61]. 
IGF-I protein was increased and peaked in weeks 4-8 
following equine flexor tendons lesion [62]. 
transforming 
growth factor β 
(TGF-β) 
Regulates cell migration, proteinase 
expression, fibronectin binding 
interactions, termination of cell 
proliferation, and stimulation of 
collagen production 
Rabbit flexor tendons subjected to transection and 
repair exhibited increased signal for TGF-β1 mRNA 
[63]. In rat tendon injury model, TGF-β1 expression 
was highest in the early phases of healing and TGF-β3 




Promotes cell migration, 
proliferation, angiogenesis, and 
matrix synthesis 
Tendons subjected to transection and repair exhibited 
an increased signal for bFGF mRNA in both resident 
tenocytes and in the fibroblasts and inflammatory cells 




Regulates protein and DNA 
synthesis at the injury site, regulates 
the expression of other growth 
factors 
PDGF was detected in canine digital flexor tendons 3, 
10, and 17 days after tendon repairs. It is a potent 
chemoattractant for macrophages and fibroblasts and 






Significant expression of VEGF occurred at the canine 
flexor tendon repair site at 7 days post-operatively, 





Maintains tendon homeostasis, 
promotes matrix synthesis and cell 
proliferation 
BMP-12, -13, and -14, were dramatically elevated at 1 
week and gradually decreased thereafter in rat 





Regulates matrix synthesis and 
organization 
CTGF showed high level of gene expression over a 21-
day period of early chicken flexor tendon healing [68]. 
CTGF was moderately expressed across all time points 
in both the insertion and mid-substance in a rat 
supraspinatus tendon repair model [67]. 
 
Another noteworthy issue concerns tendon healing is the identification of individual 
element of the adult tissue that hinders tendon regeneration. Controversial discoveries have been 
made in attempts to elucidate individual negative elements in adult tendon healing. For instance, 
the adult microenvironment appears not an impediment to scarless tendon regeneration in some 
cases, for fetal tenocytes used to fill the adult partial tenotomy defect displayed no scar formation 
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[69]. This finding suggests that the lack of sufficient healing is an issue intrinsic to aged cells. 
Conversely, embryonic-like fibrillogenesis by adult human tendon fibroblasts was achieved 
when cultured in a contracted fibrin gel, indicating an opposing conclusion:  the adult 
biochemical/mechanical milieu inhibits the regenerative potential of tendon cells [70]. Taken 
together, it remains unclear why adult tendons fail to regenerate. 
1.2 TENDON TISSUE ENGINEERING 
In cases of severe tendon injury, surgical intervention may be employed to repair or 
replace the damaged tendon with autografts, allografts, xenografts, or prosthetic devices. In the 
U.S. alone, around 45% of the 32 million musculoskeletal injuries each year involve tendon, 
ligament and joint capsule, in which tendon injuries are especially common and require over 
120,000 surgical repairs annually [71]. However, the clinical outcomes remain unsatisfactory due 
to limitations including donor site morbidity, failure rates, risk of injury recurrence and limited 
long-term function recovery [72-74]. These limitations have spurred the development of tissue 
engineering strategies, which combine therapeutic cells, biomimetic scaffolds, bioactive 
molecules, and ex vivo mechanical stimulation to create functional replacements or to amplify 
the innate healing capacity of injured tendon tissue (Fig. 6). Ultimately, tendon issue engineering 
aims at improving the quality of healing in order to achieve sufficient restoration of tendon 
function. 
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Figure 6. An overview of repair approaches for tendon injuries. Surgical interventions and biophysical 
stimulation are currently used in clinical care. Meanwhile, tissue engineering strategies are the cutting-edge of 
tendon healing and regeneration. Engineered replacement of injured tendon using a combination of cells, bioactive 
molecules, and scaffolds is under intensive investigation. 
1.2.1 Cells 
Cells that have been used in tendon tissue engineering include TCs, tendon-derived 
stem/progenitor cells (TSPCs) and mesenchymal stem cells (MSC). TCs, as discussed above, are 
responsible for building and maintaining the unique tendon ECM consisting of collagen, 
proteoglycans and glycoproteins. TCs were found to be able to deposit collagen and express 
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tendon markers in vitro including SCX, TNMD, and DCR in response to growth factors [75]. 
Tendon defects bridged by an autologous TC-engineered graft demonstrated improved 
mechanical strength and matrix deposition compared to the cell-free groups [76]. Compared to 
terminally differentiated TCs, dormant tendon-specific adult stem cells, known as TSPCs, appear 
to have a higher regenerative potential. These cells possess common stem cell characteristics 
such as clonogenicity, multipotency and self-renewal capacity [38]. In this regard, TSPCs have 
been intensively studied and applied to tendon tissue engineering. TSPCs seeded in fibrin glue 
led to superior tendon repair both histologically and biomechanically compared to fibrin glue 
alone [77]. However, despite the growing knowledge in the functionality of TCs and TSPCs in 
tendon tissue engineering, harvesting autologous tendon cells could lead to secondary tendon 
defects at the donor site. Moreover, the relatively hypocellular nature of tendon tissue impedes 
the use of autologous tendon cells in large scale. 
To this end, adult MSCs have been considered as an alternative cell source to address this 
limitation, for they are easily accessible, expandable to large quantity, and do not cause major 
donor site morbidity. Due to the shared self-renewal and multi-lineage differentiation potential, 
MSCs from a variety of tissues have been applied to tendon tissue engineering. Bone marrow 
MSCs (BMSCs), for instance, has been extensively used to populate various graft materials and 
demonstrated promising outcomes including significantly increased tendon-related gene 
expression, higher DNA content, and enhanced mechanical strength [78-81]. While the tendon 
tissue engineering potential of BMSCs has been carefully explored, less attention has been paid 
to adipose-derived mesenchymal stem cells (ASCs). Compared to BMSCs, ASCs are (1) 
harvested by less invasive procedures, and (2) available in greater quantities, for human adipose 
tissue is ubiquitous and can be isolated in large quantities with little donor site morbidity or 
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patient discomfort [82]. Moreover, the greater stem cell yield rate of adipose tissue than that of 
other stem cell reservoirs is another factor that contributes to the suitability of ASCs for 
regenerative medicine: 1x107 adipose stromal/stem cells are reported being isolated from 300 ml 
of lipoaspirate [83]. In other words, ASCs account for approximately 2% of nucleated cells in 
processed lipoaspirate, leading to an estimated yield rate of 5,000 fibroblast colony-forming units 
(CFU-F) per gram of adipose tissue, in contrast to only 100–1,000 CFU-F per milliliter of bone 
marrow [84].  
For the purpose of facilitating tendon healing and regeneration, ASCs need to proliferate 
and then undergo appropriate tenogenic differentiation to adopt tendon cell phenotype and 
deposit tendon-specific matrix in order to develop into a functional replacement tissue at sites of 
injury. Nevertheless, despite the extensive exploration of the differentiation potential of ASCs, 
the tendon cell lineage commitment of ASCs remains elusive and controversial. For instance, 
murine and canine ASCs demonstrated up to 6-fold of upregulation in SCX expression when 
treated with 100 ng/ml of GDF-5 for 1 week, whereas equine ASCs cultured in 3D collagen 
scaffold displayed no such trend toward tendon cell lineage with GDF-5 treatment [85-87]. 
Furthermore, as described below, the contradictory findings regarding the tenogenesis potential 
of human ASCs (hASCs) adds uncertainty to the established differentiation protocol. Goncalves 
et al. succeeded in acquiring tendon phenotype of abdominal hASCs along with aligned collagen 
pattern that resembles the native tendon ECM through TGF-β1 treatment. Meanwhile, this 
research team also reported the efficacy of a group of other growth factors on partial induction of 
tendon phenotype of hASCs [88]. However, Eagan et al. questioned the suitability of hASCs for 
tendon tissue engineering and showed the lack of any significant and consistent up-regulation in 
the expression of COL I, TNC, or SCX, in hASCs treated for up to 4 weeks with TGF-β1 or 
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IGF-I [89]. Lastly, hASCs cultured in standard growth medium demonstrated lower SCX 
expression compared to TSPCs, suggesting the lack of spontaneous tenogenesis of hASCs in the 
absence of proper induction [90]. Due to the inconsistent tenogenesis manifested by ASCs, their 
potential as the cellular component for tendon tissue engineering is not sufficiently exploited. To 
date, ASCs are used for tendon tissue engineering primarily as a means to improve 
vascularization, matrix deposition, and implant integration, with little consideration has been 
paid to their potential ability to recapitulate tendon cell phenotype if provided with proper tendon 
microenvironment. There is thus a critical need to explore and develop a robust tenogenesis 
protocol for hASCs. 
1.2.2 Scaffolds 
Scaffolds are another crucial element for tendon tissue engineering. They provide 
temporary biomechanical support to the healing tissue until deposition of the newly synthesized 
native matrix, and thereby preventing tendon re-rupture. In addition, scaffolds possessing desired 
features should be able to enhance tendon healing through directing cell proliferation, promoting 
matrix production, and organizing the matrix into aligned pattern. Scaffolds may be modified to 
improve regenerative events through approaches such as surface modification, growth factor 
adsorption, and mechanical stimulation-mediated cellular remodeling [91]. Commonly used 
scaffolds for tendon tissue engineering can be divided into three categories: (1) native tendon 
matrices, (2) synthetic polymers, and (3) derivatives of naturally occurring proteins. 
Scaffolds derived from native tendon tissue theoretically retain natural biomechanical and 
biochemical properties, and thereby may serve as a biomaterial to support tendon healing. [92]. 
The effective removal of antigenic epitopes presented by residing cells within xenogeneic and 
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allogeneic tissues and organs is essential to avoid or minimize the adverse immune response or 
overt immune-mediated rejection by recipients of ECM scaffold material [92, 93]. In contrast, 
most molecules that constitute the ECM are conserved across species and therefore well tolerated 
in recipients. Commonly used methods of decellularization have been carefully reviewed by 
Badylak et al., including a combination of physical and chemical treatments [92, 94]. For 
instance, cell lysis agents such as tri(n-butyl)phosphate (TnBP), sodium dodecyl sulfate (SDS) 
and Triton X-100 in combine with sonication, agitation and freeze-thaw cycles are often used to 
disrupt cell membranes, release cell contents and facilitate the subsequent rinsing and removal of 
cell remnants from the ECM. The goal of any decellularization protocol is to remove the cellular 
materials while preserve the composition, mechanical integrity and biological activity of the 
remaining ECM. The decellularized allografts or xenografts are then developed into 
biocompatible and functional delivery vehicles for cells, therapeutic gene vectors, and other 
biological agents [95-97].  
Scaffolds prepared from natural proteins and derivatives are an alternative option for 
tendon tissue engineering. For instance, as the major structural protein of tendon tissue, collagen 
and its derivative, gelatin, exhibit bio-functionality in supporting cell adhesion and cell 
proliferation [98, 99]. Cells encapsulated within collagen/gelatin hydrogels are easily distributed 
homogeneously by mixing during gel preparation without the need for any further scaffold 
modification. Collagen-derived scaffolds may be further modified by cross-linking or co-
fabricating with other materials to improve the mechanical strength or hydropholicity [30, 100, 
101]. For instance, methacrylate pendant groups can be conjugated to the amine groups on 
gelatin molecules and covalently crosslinked in the presence of proper initiator. In this regard, 
our lab has succeeded in creating a methacrylated gelatin (mGLT) hydrogel by using cell 
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compatible, visible light (VL)-activated initiator to crosslink methacrylate groups [102]. More 
importantly, the crosslinkable nature of this material allows the integration between mGLT and 
other forms of scaffold, suggesting the utility of mGLT in developing composite scaffold 
consisting of multiple components. The details of scaffold development and characterization will 
be presented in the following chapters. 
Beyond modified native materials, a great number of biodegradable/biocompatible 
synthetic polyester materials have been applied to tendon tissue engineering, including poly--
caprolactone (PCL), polyglycolic acid (PGA), poly-L-lactic acid (PLLA) and their copolymer 
polylactic-co-glycolic acid (PLGA). Featured by relatively simple and well-defined chemical 
composition, scaffolds fabricated from these materials are tunable in physical and chemical 
properties and thereby highly versatile for clinical commitments. In terms of tendon tissue 
engineering, polyester scaffolds are often used to bridge the defect and serve as a vehicle to 
deliver and immobilize therapeutic cells to the site of injury [76, 103, 104]. Nevertheless, 
synthetic polyester materials suffer from several limitations, including absence of biochemical 
motifs for cellular attachment and accompanying inability to fully support cell activity.  
The presentation of topographical cues must be carefully designed when engineering cell-
interacting scaffold, for the micro/nano-structure of material-cell interface is known to modulate 
cellular behavior. As far as tendon tissue engineering is concerned, alignment is an important 
topographical characteristic to create in order to reproduce the aligned fibrous feature of native 
tendon tissue. The impact of scaffold alignment on tendon tissue engineering is manifold: Firstly, 
placing cells on substrate with alignment pattern leads to increased expression of tendon 
markers, such as SCX and TNMD [105, 106]. Secondly, cell extension and matrix deposition are 
also found to align along the orientation of fibers that constitute scaffold mesh [104, 107]. It is 
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noteworthy that the tenogenic influence of substrate alignment is observed across various 
mammalian species and cell types, implying a shared underlying molecular basis of cell 
substrate-sensing. It is thought that integrin, the primary cell surface receptor family for ligands 
provided by scaffolds, functionally mediate this effect due to their pivotal role in cell-substrate 
interaction and highly conserved protein sequence and conformation across species.     
1.2.3 Bioactive molecules 
As reviewed earlier, numerous growth factors have been found to be actively involved in 
tendon development and healing. Nevertheless, the application of growth factors to clinical 
tendon repair remains challenging, due to the paucity of knowledge in the spatiotemporal 
interaction and distribution of growth factors that would produce the best effects. We highlight 
here some successes that have been achieved in accelerating the healing process and 
subsequently enhancing the quality of repaired tissue through exogenous application of growth 
factors.  
The application of IGF-I to the inflammation site in rat Achilles tendon mitigated 
inflammation-induced functional deficits [108]. IGF-I also stimulated the proliferation and 
migration of fibroblasts at the site of injury, leading to increased production of collagens and 
other ECM components during the remodeling stages [52, 109]. Like IGF-I, TGF-β is involved 
in matrix synthesis in tendon healing [110]. Equally important, TGF-β signaling is able to drive 
tenogenic differentiation through the induction of SCX, indicating its potential in stem cell-based 
tendon tissue engineering (See 1.1.1 and 1.1.2). TGF-β is therefore of particular research interest 
to us in attempts to explore the tenogenic potential of MSCs. Other TGF-β super family 
members, growth differentiation factor-5 (GDF-5, also known as BMP-14) and GDF-7 (BMP-
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12) are reportedly effective in healing injured tendon tissue [111, 112]. Another frequently used 
growth factor in tendon tissue engineering is bFGF. Administered either through injection or 
scaffold-based releasing, bFGF was able to significantly increase tenogenesis and collagen type 
III level [113-115]. As was seen with IGF-I, PDGF stimulated tendon ECM protein production 
and DNA synthesis in a dose-dependent manner, and therefore improves healing [116, 117]. 
In addition to growth factors, the extracellular matrix (ECM), a complex network of 
interacting macromolecules secreted and maintained by the residing cells, is responsible for both 
biomechanical and microenvironmental signaling functions, and is therefore considered as 
potential bioactive molecules for tissue engineering. While there are many common ECM 
components, each tissue and organ possesses a unique ECM composition tailored to tissue-
specific physiologic and mechanical requirements in order to maintain a particular cell 
phenotype and functionality. In this regard, properly prepared ECM that has a complex 
composition of diverse molecules may support the cellular processes necessary for optimal 
function of the tissue and organ from which the ECM is harvested [92]. Badylak et al. has 
extensively studied and reported the bioactivity of ECM prepared from a variety of tissues, 
including urinary bladder matrix (UBM), small intestinal submucosa (SIS), brain, bone, 
esophagus, and muscle on the basis of their influence in angiogenesis, cell proliferation, cell 
migration, cell differentiation, and host tissue remodeling [118-121]. As far as tendons are 
concerned, these tissues are rich in both collagenous and non-collagenous ECM proteins (Table 
1). The influence of tendon ECM on tendon cell behavior is manifold, including regulation of 
proliferation and differentiation, as depletion of key ECM components impairs the self-renewal 
and tendon-specific gene expression of tendon progenitor cells [38]. Furthermore, hASCs and 
rabbit TSPCs seeded on decellularized tendon/ligament ECM showed improved proliferation and 
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differentiation in 2D cultures [122, 123]. However, challenges remain in understanding the 
mechanism and utility of ECM as bioactive factors for tissue engineering. On one hand, the 
combined effects of ECM composition and other environmental cues, such as tissue architecture, 
mechanical loading and presence of growth factors, are worth studying to gain further insights 
into the role of ECM biochemistry in cell activity regulation. On the other hand, the method 
employed to dissociate tissue has substantial impact on the bioactivity of subsequent 
homogeneous ECM extract. To date, acid-pepsin based enzymatic digestion on decellularized 
ECM is the most commonly used solubilization approach to obtain ECM solution containing 
peptides fragments of parent ECM molecules such as collagen, fibronectin along with embedded 
growth factors. However, the drawbacks of digestive enzyme treatment such as fragmentation of 
functional motifs and unwanted dissociation between interactive molecules might lead to the loss 
of activity of a fraction of ECM molecules. In this regard, treatment with chaotropic agent, such 
as urea, to disrupt lipid-lipid, lipid-protein, and protein-protein interactions in the ECM network 
without enzymatic digestion is considered as a promising approach to obtain a water soluble 
extract of ECM rich in non-collagenous proteins that would have otherwise been significantly 
degraded by enzyme treatment. Using this method, we have prepared a soluble fraction of tendon 
ECM (tECM) in this study and will explore the composition and bioactivity of tECM in the 
following chapters. 
1.2.4 Mechanical stimulation 
As tendons transmit force from muscles to bone, the role of mechanical loading in tendon 
biology has been extensively studied. In the context of tendon injury and repair, it is recognized 
that controlled motion of healing tendons is required to improve clinical outcomes [124]. 
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Although the optimal time span and magnitude of loading for tendon rehabilitation protocol is 
not clearly understood, it is well accepted that healing tendons should be subjected to loading in 
a controlled manner to drive favorable remodeling and functional outcomes [124]. More 
recently, the cellular and molecular basis for loading-induced healing of tendons and ligaments 
has been explored. Fibroblasts and MSCs exposed to static or cyclic uniaxial tension manifested 
increased cellular proliferation, ECM production, and tenogensis [125-127]. Integrin-dependent 
signaling is pivotal in conveying external mechanical stimulation to downstream intrinsic targets. 
For instance, Xu et al. revealed that RhoA/ROCK and focal adhesion kinase coordinate to drive 
tenogenesis of MSCs in response to mechanical stretch through the regulation of cytoskeletal 
organization [128]. Other signaling pathways, such as TGF-β, are believed to be relevant to force 
induced tenogenesis independently of cytoskeletal tension [129]. In addition to improving the 
biochemical and material properties of healing tendons, mechanical stimulation is also able to 
precondition tissue engineered constructs prior to implantation for improved in vivo outcomes. 
For example, cell-repopulated ECM demonstrated higher ultimate stress and elastic moduli after 
being cyclically stretched in bioreactors [130]. The improved mechanical properties can be 
explained in part by increased deposition of collagen fibrils in the direction of strain [131].  
Although recent research has begun to elucidate the effect of mechanical stimulation in 
improving natural healing and properties of cellular constructs prepared ex vivo, a 
comprehensive understanding is lacking regarding the influence of mechanical loading on tendon 
healing. For instance, the effect of mechanical stretch on the integration between tendon tissue 
engineering constructs and native tissue is largely unknown [132]. Moreover, the efficacy of 
growth factors injected into a tendon injury site to improve healing seems dependent on the 
mechanical environment of the tissue [133]. For example, minimal or no bone formation was 
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observed as a consequence of GDF-6 treatment when the healing rat tendons were loaded. In 
contrast, GDF-6 led to an increased formation of cartilage or bone in unloaded healing rat 
tendons [134]. Taken together, a thorough understanding of the impact of mechanical stimulation 
will be needed to realize the ultimate promise of regenerative medicine for tendon injuries. 
1.3 RESEARCH OVERIVEW 
The objective of this dissertation research is to understand the bioactivity of a soluble 
ECM fraction extracted from native tendon tissue (tECM) on the tenogenic potential of human 
adipose stem cells (hASCs). We hypothesize that tECM enhances proliferation and 
tenogenic differentiation of hASCs induced by either static tension or growth factor 
treatment. To achieve the proposed goal, this research is divided into three relevant aims.  
Specific Aim 1: Prepare and characterize the composition of tECM. Determine the 
activity of tECM on the tenogenesis of hASCs induced by mechanical loading using a 3D 
tension-bearing scaffold.  
Specific Aim 2: Determine the activity of tECM on the proliferation and TGF-β3 induced 
tenogenesis of hASCs cultured in 2D and 3D. Examine the influence of tECM on collagen 
synthesis and organization by hASCs cultured on 3D aligned fibrous scaffolds.  
Specific Aim 3: Develop a novel composite scaffold as a tendon graft consisting of 
electrospun PCL microfibers and methacrylated gelatin (mGLT). A cell-scaffold construct will 
be prepared by this scaffold seeded with hASCs to mimic the architecture and cell phenotype of 
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native tendon tissues; and also serve as a reservoir of tECM as well as other tenogenic cues for 
tendon tissue engineering.  
The following chapters detail the results of each specific aim. 
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2.0  TENDON-DERIVED EXTRACELLULAR MATRIX ENHANCES TENOGENIC 
DIFFERENTIATION OF HUMAN ADIPOSE-DERIVED STEM CELLS CULTURED IN 
3-DIMENSIONAL COLLAGEN SCAFFOLD UNDER TENSION
This chapter includes material from the following publication: 
Yang G, Rothrauff BB, Lin H, Gottardi R, Alexander PG, Tuan RS. Enhancement of 
tenogenic differentiation of human adipose stem cells by tendon-derived extracellular matrix. 
Biomaterials. 2013 Dec;34(37):9295-306. doi: 10.1016/j.biomaterials.2013.08.054. 
2.1 ABSTRACT 
Mesenchymal stem cells (MSCs) have gained increasing research interest for their 
potential in improving healing and regeneration of injured tendon tissues. Developing functional 
three-dimensional (3D) scaffolds to promote MSC proliferation and differentiation is a critical 
requirement in tendon tissue engineering. Tendon extracellular matrix has been shown to 
maintain the tenogenic potential of tendon stem cells and stimulate tenogenesis of human 
adipose stem cells (hASCs) in 2D culture. This study aims at characterizing the biological 
composition of urea-extracted fraction of tendon ECM (tECM) and its tenogenic effect on 
hASCs cultured in a 3D collagen scaffold under uniaxial tension. The tECM obtained was cell-
free and rich in ECM proteins. hASCs seeded in tECM supplemented scaffold exhibited 
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significantly increased proliferation and tenogenic differentiation. The presence of tECM also 
greatly suppressed the osteogenic differentiation of hASCs triggered by uniaxial tension. In 
addition, tECM-supplemented constructs displayed enhanced mechanical strength, accompanied 
by reduced expression and activity of MMPs in the seeded hASCs, indicating a regulatory 
activity of tECM in cell-mediated scaffold remodeling. These findings support the utility of 
tECM in creating bio-functional scaffolds for tendon tissue engineering.  
2.2 INTRODUCTION 
Tendons are fibrous tissues composed of densely packed collagen fiber bundles that 
connect muscle to bone and function in transmitting force from muscle to bone [50]. These 
tissues bear high tensile force and are therefore prone to injuries such as rupture and laceration. 
In the U.S. alone, tendon, ligament, and joint capsular injuries account for 45% of the 32 million 
musculoskeletal injuries each year [71]. It was estimated that about 200,000 tendon and ligament 
repair surgeries are performed annually in the U.S. [135]. Unfortunately, the natural healing 
process of tendons is slow and the resulting tissue is inferior in structure and function due to their 
hypocellular and hypovascular nature [74]. In cases of severe tendon injury, surgical treatments 
may be used to repair or replace the damaged tendon with autografts, allografts, xenografts, or 
prosthetic devices [136]. However, the clinical outcomes remain unsatisfactory due to limitations 
including donor site morbidity, high failure rates, risk of injury recurrence and limited long-term 
function recovery [48, 137, 138]. These limitations have spurred the development of tissue 
engineering strategies, which use a combination of cells, scaffolds and bioactive molecules, to 
treat tendon injuries [91, 112, 115, 139].    
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The use of adult mesenchymal stem cells (MSCs) as the cellular component for tendon 
tissue engineering has been of particular research interest in recent years [136]. While the most 
common approach to direct MSCs to differentiate into a specific lineage in vitro is through 
growth factors stimulation, differentiation of MSCs into tendon cells (tenogenesis) can be 
induced through uniaxial tension in three-dimensional (3D) culture [91, 126, 140]. For this 
purpose, a variety of biomaterials have been used as the scaffold to convey desired mechanical 
loads to the seeded cells. For example, when cultured under cyclic stretch, MSCs seeded on 
polyester fibrous scaffolds demonstrated enhanced tenogenesis [141]. Similarly, collagen gel has 
been used as a scaffold for MSC culture under uniaxial tension to create engineered tissues 
mimicking native tendons and ligaments [125, 126, 142]. However, none of these load-
transmitting scaffolds possesses ideal bio-functionality for successful tendon tissue engineering, 
which refers to the ability to support cell proliferation, differentiation into tendon-forming cells 
without ossification, and matrix remodeling to generate a functional replacement at the wound 
site [50, 143, 144]. Therefore, the need remains in tendon tissue engineering to develop 
supportive scaffolds with desired bio-functionality. 
To date, a number of extracellular matrices have been used in various approaches to 
address the lack of bio-functionality in tissue engineering scaffolds [92]. In native tissues, the 
extracellular matrix (ECM), a complex network of interacting macromolecules that occupies the 
space between cells, is principally responsible for both biomechanical and microenvironmental 
signaling functions [145]. While there are many common ECM components, each tissue and 
organ possesses a unique ECM composition tailored to tissue-specific physiologic and 
mechanical requirements in order to maintain a particular cell phenotype and functionality [92]. 
Tendon tissues are rich in ECM components and contain fewer cells than most tissues, and many 
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of the tendon ECM components as well as growth factors embedded in the ECM appear to be 
retained in decellularized tendons [146]. The influence of ECM on tendon cell behavior is many-
fold, including regulation of proliferation and differentiation, as depletion of key ECM 
components impairs the self-renewal and tendon-specific gene expression of tendon progenitor 
cells [38]. Thus, the use of native tissue matrices in scaffold synthesis may be very beneficial in 
tissue engineering approaches to tendon repair. For example, both human adipose derived stem 
cells (hASCs) and rabbit tendon stem/progenitor cells (rTSPCs) seeded on decellularized 
tendon/ligament ECM showed improved proliferation and differentiation in a 2D format [122, 
123]. These findings, taken together, suggest that tendon ECM may be included in 3D scaffold to 
enhance tenogenic differentiation of encapsulated MSCs, particularly in constructs cultured 
under tensile conditions, to produce a more functional neo-tendinous tissue.  
In this study, we hypothesize that incorporation of native tendon ECM components will 
enhance the bio-functionality of 3D tension-bearing scaffold. To test this hypothesis, tendon 
ECM was extracted with urea and incorporated into a 3D collagen scaffold into which hASCs 
were seeded, and the construct was placed in culture under uniaxial tension for over 7 days. Cell 
proliferation, differentiation, and matrix remodeling capacity within these tECM-enhanced 
constructs were analyzed, and the influence of tECM on the mechanical properties of the 
constructs was assessed.  
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2.3 MATERIALS AND METHODS 
2.3.1 Tissue harvest 
Bovine Achilles tendons were harvested from eight 2-3 week old bovine hind legs 
(Research 87). The midsubstance of the tendinous portion between the distal end of 
gastrocnemius muscle and the calcaneal insertion was dissected and immediately immersed in 
phosphate buffered saline (PBS; Gibco) supplemented with 5 mM ethylenediaminetetraacetic 
acid (EDTA; Sigma-Aldrich), 0.5 mM phenylmethylsufonyl fluoride (PMSF; Sigma-Aldrich) 
and 1 x Penicillin-Streptomycin (P/S; Gibco), and stored at -20˚C until processing. EDTA, 
PMSF, and P/S were added for their metalloproteinase inhibition, serine protease inhibition and 
anti-bacterial effect, respectively.    
2.3.2 Extraction of tECM 
To obtain tECM powder, Achilles tendons were frozen in PBS at -80 ˚C and then thinly 
sliced at 40 µm thickness using a cryotome (Leica CM 1850). The tendon sections were 
pulverized in liquid nitrogen with a mortar pestle, and the tissue powder was then decellularized 
by incubation in 1% Triton X-100 (Sigma-Aldrich) in PBS under continuous agitation for 24 h at 
4˚C, followed by three washes, 30 min each in PBS. The decellularized material was treated with 
200 U/ml DNase and 50 U/ml RNase (Worthington) solution at 37˚C for 12 h and then washed 
in PBS 6 times, 30 min for each wash. After nuclease digestion, the preparation was extracted 
with 3 M urea (Sigma-Aldrich) in water with gentle agitation for 3 days at 4˚C. The suspension 
was then centrifuged for 20 min at 1,500 g to collect the extract supernatant. Urea was removed 
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by dialysis of the extract contained in dialysis cassettes (3,500 MWCO, Thermo Scientific) 
against deionized water for 2 days at 4˚C. Water was changed every 4 h. The dialyzed tECM 
extract was transferred into centrifugal filter tubes (3,000 MWCO, Millipore) and spin-
concentrated by 10 folds for 30 min at 1,500 g. The final ECM solution was filter-sterilized 
through PVDF syringe filter units (0.22 μm, Millipore), protein concentration determined using 
the BCA assay (Thermo Scientific), and then stored at 4˚C until further use. Total proteins were 
extracted from homogenized original tendon tissues by TM buffer (Total Protein Extraction Kit, 
Millipore) and served as a control. 
2.3.3 SDS-PAGE and Western blot assay 
For SDS-PAGE and Western blotting, protein samples of the same concentration was 
mixed with loading buffer and reducing agent (Life Technologies), and heated at 70˚C for 10 
min. Protein samples were then loaded into wells of pre-cast NuPAGE gels (NuPAGE Bis-tris 
Mini Gel, Life Technologies) and separated by electrophoresis in MOPS SDS running buffer for 
50 min at constant 200 V. Proteins were transferred onto PVDF membranes using the iBlot dry 
blotting system (Invitrogen). After incubating in 5% powder milk in TBST for blocking, 
membranes were incubated at 4˚C overnight with the following primary antibodies: mouse anti-
fibronectin, sheep anti-decorin, goat anti-biglycan or rabbit anti-fibromodulin (Abcam). The 
membranes were then washed in TBST 6 times and incubated with corresponding horseradish 
perioxidase conjugated secondary antibodies for 1 h at room temperature. Blots were allowed to 
react with chemiluminescence substrate (West Dura Extended Duration Substrate, Thermo 
Scientific) for 5 min and imaged with a CCD camera gel imaging system. (FOTODYNE) 
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2.3.4 Cell isolation and culture 
hASCs were isolated from the lipoaspirate-derived fat tissue from three female donors 
(28, 32, and 36 years old) with Institutional Review Board approval (University of Pittsburgh) 
using an automated cell isolation system (Tissue Genesis). hASCs were cultured in growth 
medium (DMEM-high glucose, 10% fetal bovine serum (FBS), 100 units/ml penicillin and 100 
mg/ml streptomycin, Gibco). At 80% confluence, cells were detached with 0.25% trypsin in 1 
mM EDTA (Gibco) and passaged. All experiments were performed with passage 3 (P3) hASCs. 
To reduce donor to donor variation, cells from the three donors were pooled in equal number.  
2.3.5 3D culture of cells under static tension 
To study the combined effect of mechanical stimulation and tECM on hASCs, the 
Flexcell Tissue Train Culture System (Flexcell) was employed. Briefly, hACSs at P3 were 
trypsinized from cell culture flasks and mixed at 1 x 106 cells/ml with 0.5% collagen type I 
solution at neutral pH (Purecol EZ, Advanced Biomatrix) containing either 10% (v/v) 800 µg/ml 
collagen type I solution (Purecol EZ, Advanced Biomatrix) or 10% (v/v) 800 µg/ml tECM 
solution. To set up 3D gel constructs, linear Trough LoadersTM were placed in baseplates beneath 
the flexible membrane of Tissue TrainTM culture plate so that the anchor stems were aligned with 
the long axis of the Trough Loader. A vacuum was applied to deform the membrane into the 
conformation of the trough. 300 μl of cell-gel suspension was then pipetted into each well and 
allowed to gel at 37˚C for 2 h. After the gel set, the vacuum was released and the culture plates 
were dissociated from the base plates. Gels appeared as linear bands attached at each anchor end 
in the well (Fig. 9 A), and uniaxial tension was generated as a result of cell traction that caused 
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the gel to contract. hASCs were also seeded into 6-well tissue culture plates as 2D controls at 1 x 
105 cells/well. Growth medium was added to each well and changed every 3 days. Contraction 
rate was determined from digital images taken on days 1, 3 and 7 of culture analyzed in Image J 
(NIH). Total construct area between the anchors divided by the length between anchors was 
defined as the average width. Constructs were also harvested at the same time points for other 
analyses.  
2.3.6 Scanning electron microscopy (SEM) 
hASC-seeded 3D constructs were collected at day 1, 3 and 7, washed twice in PBS, fixed 
with 2.5% glutaraldehyde in PBS for 2.5 h at room temperature, and then rinsed in PBS and 
dehydrated in a graded ethanol series. After critical point drying, samples were mounted on 
aluminum stubs, sputter-coated with 3.5 nm gold, and examined by SEM (field emission, JEOL 
JSM6335F), operated at 3 kV accelerating voltage and 8 mm working distance. The external 
surface of the central part of the constructs was selected for imaging. 
2.3.7 Cell viability analysis 
On days 1, 3 and 7, MTS assay (CellTiter 96 Aqueous One Solution Cell Proliferation 
Assay, Promega) was performed according to the manufacturer’s instructions to determine cell 
viability for cells from each group. Briefly, the MTS reagent was thawed and diluted 1:5 in 
phenol red free medium (Gibco). 3 ml working solution was added into each flexcell well and 
incubated for 3 h at 37˚C. The reduced reagent was then transferred to a 96 well plate and A490 
determined spectrophotometrically using a microplate reader (BioTek), with reagent blank as 
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control. The readings were normalized to the pure collagen group at each time point. For 
Picogreen (Quant-iT PicoGreen dsDNA Reagent, Invitrogen) assay, samples were first washed 
twice in PBS for 5 min and then digested in 500 µg/ml papain (Sigma-Aldrich) at 60˚C for 2 h. 
100 µl 1x Picogreen working solution in TE buffer was added into 100 µl papain solution 
containing one digested gel construct and incubated for 2 min protected from light. The 
fluorescence of samples and standards were measured using a fluorescence microplate reader 
(excitation 480 nm, emission 520 nm, BioTek), with reagent blank as control.  The fluorescence 
values were compared against a lambda phage DNA standard curve to determine the DNA 
concentration. The calcein acetoxymethyl (calcein-AM)/ethidium homodimer-1 (EthD-1) based 
Live/Dead assay (Invitrogen) was performed to confirm the cell viability. At days 1 and 7, 
constructs from each group were incubated in calcein-AM and EthD-1 (diluted 1:1000 in growth 
medium) for 1 h, and then visualized by fluorescence microscopy. For nuclear staining, tendon 
tissues were placed on glass slides and incubated with 500 µl 300 nM diamidino-2-phenylindole, 
dilactate (DAPI, D3571 Invitrogen) in PBS for 1 min. The samples were then washed 3 times in 
PBS and viewed using fluorescence microscopy. 
2.3.8 Histology  
Tendon tissues and Flexcell constructs were washed 3 times in PBS, fixed for 12 h in 
10% phosphate buffered formalin (Fisher Scientific) at room temperature, dehydrated in serial 
ethanol solutions followed by xylene, and embedded in paraffin. The embedded samples were 
sectioned at 10 µm thickness, deparaffinized in xylene, rehydrated, and stained with hematoxylin 
and eosin (H&E), or picosirius red for visualization.  
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2.3.9 Real-time PCR analysis  
At each time point, total RNA was isolated using an RNA extraction Kit (Qiagen) 
according to the manufacturer’s protocol. RNA concentrations were determined based on A260 
using the Nanodrop spectrophotometer (Thermo Scientific). First-strand cDNA was synthesized 
with oligo(dT) primers using a cDNA synthesis kit (Invitrogen). Quantitative real-time PCR was 
performed using SYBR green Supermix in a Step One Plus real-time PCR system (Applied 
Biosystem, Life Techonologies) and then analyzed by comparative Ct quantification (ΔΔ-Ct 
method). Primers were used for tenogensis marker genes including scleraxis (SCX) and 
tenomodulin (TNMD), osteogenesis marker genes including runt-related transcription factor 2 
(RUNX2), alkaline phosphatase (ALP) and osteocalcein (OCN), ECM protein genes including 
collagen I (COL I), collagen III (COL III), decorin (DCR) and tenascin-C (TNC), and matrix 
metalloproteinase (MMP) genes including MMP-1, -2, -8, -9 and -13. The targets and sequences 
of primers are shown in Table 3 except tenomodulin, which was purchased from Qiagen (Hs 
TNMD, QuantiTect Primer Assay, Qiagen). Primer specificity and product sizes were confirmed 
by melting curve analysis and agarose gel electrophoresis. The expression level of each gene was 







Table 3. Primer sequences used in assessment of gene expression by real time PCR analysis 
 
2.3.10 Mechanical test 
Mechanical testing was performed using a mechanical tester (Bose 3230) consisting of a 
2.45 N (250 g) load cell with accuracy of 0.004 N. At days 3 and 7, constructs were washed 
twice in PBS for 5 min, and then separated from the rubber membrane, while remaining attached 
Gene Primer sequence (5’-3’) Product size (bp) 
GAPDH Forward CAAGGCTGAGAACGGGAAGC 194 
 
Reverse AGGGGGCAGAGATGATGACC  
SCX Forward ACACCCAGCCCAAACAGA 65 
 
Reverse GCGGTCCTTGCTCAACTTTC  
COL I Forward GGCTCCTGCTCCTCTTAGCG 123 
 
Reverse CATGGTACCTGAGGCCGTTC  
COL III Forward CAGCGGTTCTCCAGGCAAGG 179 
 
Reverse CTCCAGTGATCCCAGCAATCC  
DCR Forward CGCCTCATCTGAGGGAGCTT 205 
 Reverse TACTGGACCGGGTTGCTGAA  
TNC Forward GGTGGATGGATTGTGTTCCTGAGA 328 
 Reverse CTGTGTCCTTGTCAAAGGTGGAGA  
RUNX2 Forward CAACCACAGAACCACAAGTGC 196 
 Reverse TGTTTGATGCCATAGTCCCTCC  
ALP Forward TGGAGCTTCAGAAGCTCAACACCA 454 
 Reverse ATCTCGTTGTCTGAGTACCAGTCC  
OCN Forward ATGAGAGCCCTCACACTCCTC 294 
 Reverse GCCGTAGAAGCGCCGATAGGC  
MMP-1 Forward GGGGCTTTGATGTACCCTAGC 142 
 Reverse TGTCACACGCTTTTGGGGTTT  
MMP-2 Forward GATACCCCTTTGACGGTAAGGA 112 
 Reverse CCTTCTCCCAAGGTCCATAGC  
MMP-8 Forward TTTTGATGCCGAAGAAACATGGA 97 
 Reverse GTGAGCGAGCCCCAAAGAA  
MMP-9 Forward TGTACCGCTATGGTTACACTCG 97 
 Reverse GGCAGGGACAGTTGCTTCT  
MMP-13 Forward ACTGAGAGGCTCCGAGAAATG 103 
 Reverse GAACCCCGCATCTTGGCTT  
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to the anchors. The construct was then fixed between two clamps through the anchors (Fig. 13 
A). Samples were pre-loaded to remove slack and then stretched 10 mm at an elongation rate of 
0.02 mm/sec. The load/displacement curve was recorded. For each construct, maximum force 
recorded at the peak of the curve was defined as maximum load (N), and the slope of the linear 
region in load/displacement curve as stiffness (N/mm).  
2.3.11 MMP activity assay 
MMP activity in conditioned medium was assayed. Briefly, hASC-seeded constructs 
were cultured in serum- and phenol red-free medium (DMEM + 1% ITS (Gibco) + penicillin/ 
streptomycin) for up to 7 days. At day 1, 3 and 7, conditioned media were collected and 
incubated with an equal volume of 1 mM 520 MMP FRET substrate XI working solution 
(AnaSpec) in a black 96-well plate at 37 ˚C for 1 h. Fluorescence was measured every 5 min 
(excitation 485 nm, emission 528 nm). The reaction rate calculated from the slope of the linear 
portion of the kinetics curve represented the activity level of MMPs secreted from hASCs in 
scaffolds.    
2.3.12 Statistical analysis 
Data are presented as mean ± standard deviation (SD). Each experiment was performed 
independently at least three times. Two-tailed Student’s t-test and one-way ANOVA followed by 
Bonferroni post hoc test were used for determining statistical significance of two-group 




2.4.1 Characteristics of tendon-derived ECM 
Decellularization was verified by the lack of cell nuclei using H&E and DAPI staining  
(Fig. 7 A-D) and by the reduction in DNA content after Triton X-100 and subsequent nuclease 
treatment compared to that of original tendon tissues (Fig. 7 E, n=4). The combination of Triton 
X-100 and subsequent nuclease treatment significantly reduced double-stranded DNA content 
compared to untreated tendon tissues (p<0.01).  
 
Figure 7. Decellularization of tendon tissue. Tendon tissue was stained with DAPI (A, C) or H&E (B, D). 
Prior to decellularization (A, B), abundant cell nuclei are visible. After decellularization (C, D), nuclei are rarely 
seen in the tissue, whereas ECM remains. (E) Triton X-100 treatment alone (Triton X-100 treated) and with 
subsequent nuclease treatment (Triton X-100 + DNase treated) both significantly reduce the double stranded DNA 
content compared to untreated tendon tissues (Raw Tendon). Scale bar=100 µm; **, p<0.01 compared to Raw 
Tendon group, n=4 
 41 
SDS-PAGE analysis revealed that tECM contained a number of low molecular weight 
(<100 KD) protein components that were absent in commercial bovine collagen type I solution 
(Fig. 8 A), but present in total tendon extract. This observation indicated the preservation of 
biochemical composition of tendon tissue after decellularization and protein extraction. Western 
blot assay showed that at least four types of critical tendon ECM protein components were 
present in this tECM extract: decorin, biglycan, fibromodulin and fibronectin (Fig. 8 C). In 
contrast, none of these four types of proteins was detected in the collagen type I sample. To 
confirm the consistency of the extraction method, the compositions of tECM extracts harvested 
independently from 4 calves were analyzed by SDS-PAGE and Western blot assay (Fig. 8 B, D). 
The yield, expressed as the final protein content in the extract solution divided by the wet weight 




Figure 8. Characterization of tECM by SDS-PAGE (A, B) and Western blot assay (C, D). (A) Both 
original tendon tissue (Tendon) and tECM contain abundant low molecular weight proteins (<100 KD) that are 
absent in collagen type I solution (Collagen). (C) At least four types of matrix proteins, biglycan, decorin, 
fibromodulin and fibronectin, are detected in ECM solution. (B, D) The consistency of the extraction procedure is 
confirmed by a nearly identical protein profile and immunoreactivity between four independent extracts of tECM 
(tECM 1-4) from tissues of 4 different calves. 
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2.4.2 Constructs and cell morphology 
Under static tension, all hASC-gel complexes gradually formed cylindrical 3D constructs 
with each end attached to an anchor stem (Fig. 9 A). With the passage of time, all constructs 
contracted to form narrower bands, presumably due to the combined effect of cell traction and 
matrix remodeling (Fig. 9 B). The width of the tECM supplemented constructs was significantly 
greater than that of pure collagen constructs at days 1, 3 and 7 (Fig. 9 C, n=6, p<0.05). Three 
days after gel setting, the pure collagen constructs contracted their diameter by 62.6% and 
tECM-supplemented constructs by 53.6% on average. Over a 7-day period, the final diameters 
were 69.9% and 64.4% smaller than the starting values for pure collagen constructs and tECM-
supplemented constructs, respectively.  
 
Figure 9. Contraction of constructs. (A) Top view of Tissue Train culture plate together with gel construct 
shows that the cell-collagen construct was fixed at each end by bonding to the nylon anchor stem. (B) Reduction in 
contraction is seen in the tECM-supplemented collagen constructs (right panels) compared to the collagen gel 
contructs (left panels). (C) The average width of the tECM-supplemented constructs is significantly higher than that 






Cell morphology within the constructs was analyzed by SEM and histological staining. 
SEM revealed the presence of wavy, randomly oriented collagen fibrils in both collagen only and 
tECM-supplemented scaffolds. At day 1, cells in the tECM-supplemented scaffold demonstrated 
well aligned cell bodies and extensions along the longitudinal axis of the scaffold (Fig. 10 D, 
white arrows), whereas cells in the pure collagen scaffold were more randomly oriented (Fig. 10 
A, white arrows). Higher magnification images showed that cells within tECM-supplemented 
scaffolds projected more fine extensions attached to collagen fibrils (Fig. 10 E) than that of pure 
collagen scaffolds, where extensions were fewer and only appeared at the extremities of cells 
(Fig. 10 B). The difference in cell orientation between scaffold types was no longer evident at 
day 7, when most cells were longitudinally aligned, and cell density was dramatically higher than 
that of day 1 in each group (Fig. 10 C, F).  H&E staining of longitudinally sectioned samples 
revealed uniform cell distribution within the constructs on day 1 (Fig. 10 G, J). At day 7, the 
difference in construct width was apparent between the pure collagen construct (Fig. 10 H) and 
the tECM-supplemented construct (Fig. 10 K), in agreement with the results of gross width 
measurement. Longitudinally elongated cytoplasm and nuclei were apparent in cells in both 
construct types. Higher cell number was found in the peripheral region of the tECM-
supplemented constructs, resembling an epitendinous sheath surrounding native tendon fibers 








Figure 10. Examination of scaffold structure, cell morphology and distribution by SEM (A-F) and H&E 
staining (G-L). Cells in the tECM-supplemented scaffolds exhibit aligned cell bodies and extensions along the 
longitudinal axis of the scaffold (D, white arrows), whereas cells in the pure collagen scaffold are more randomly 
oriented (A, white arrows). Higher magnification images show more abundant thin extensions from the cell body 
attached to the collagen fibrils in tECM-supplemented scaffolds (E, white arrows) compared to pure collagen 
scaffolds (B, white arrows). (C, F) After 7 days of culture, most cells assume an elongated spindle shape along the 
longitudinal axis of the scaffold. (G, J) H&E staining demonstrates uniform cell distribution along the depth of the 
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constructs 1 day after gel setting. (H, I, K, L) At day 7, cells in each group are longitudinally aligned. (I, L) 
Interestingly, intense hematoxylin nuclear staining is evident at the peripheral region of tECM-supplemented 
scaffolds (L, black arrows). Such superficial cell aggregate is not seen in pure collagen scaffolds.  
2.4.3 Cell viability and proliferation  
At days 1, 3 and 7, cell metabolic activity and cell number were determined using MTS 
assay and Picogreen staining, respectively (n=3). Cells seeded on tECM-supplemented scaffolds 
demonstrated significantly increased metabolic activity (p<0.05) and cell number (p<0.01) 
compared to that of pure collagen scaffolds at day 7, suggesting that the presence of tECM 
greatly promoted cell proliferation and cell activity in a 3D culture under uniaxial tension (Fig. 
11 A, B).  A high percentage of viable cells were seen by Live/Dead assay in both pure collagen 
and tECM-supplemented scaffolds 24 hours after gel setting, indicating that the tECM solution 
was non-toxic to cells. At day 1, most cells were round in shape, and evenly distributed inside 
the scaffolds. After 7 days of culture, cells retained a high rate of viability and exhibited 
longitudinal elongation, in agreement with histological analysis (Fig. 11 C).  
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Figure 11. Cell viability assays. (A) After 7 days of culture, cell number, represented by DNA content, is 
significantly higher in the tECM group. (B) Similarly, cells in the tECM group demonstrate increased metabolic 
activity, as evidenced by elevated level of reduced MTS reagent. (C) Live/Dead cell viability staining (green, live 
cells; red, dead cells) showed a high percentage of viable cells, round shaped and evenly distributed, in each group 1 
day after seeding. After 7 days of culture, cells retain a high rate of viability and exhibit longitudinally elongated cell 
bodies.*, p<0.05; **, p<0.01; scale bar=100 μm, n=3 
2.4.4 Cell differentiation 
Gene expression of ASCs in both 2D and 3D culture (n=5) were quantified at the mRNA 
level by real-time PCR. The results showed that the 3D scaffolds under uniaxial tension 
promoted tenogenic differentiation of hASCs, as compared to 2D controls, and that tenogenesis 
was further enhanced by tECM supplementation (Fig. 12 A-C). The expression of SCX was 
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significantly higher in the tECM group than the pure collagen group at days 1 and 3. Both 3D 
groups demonstrated an up-regulation of SCX at all three time points compared to 2D culture. 
The expression of TNMD was found significantly higher in the tECM group than the 2D and the 
3D collagen group at day 3, but the difference between the two 3D groups was negligible at day 
7, when they were both higher than the 2D group. The expression pattern of TNC was similar 
among all three groups at the first two time points, but was significantly higher in the tECM 
group at day 7. Taken together, these findings demonstrated that hASCs underwent tenogenic 
differentiation in 3D culture under tension, and that exposure to tECM improved this lineage-
specific differentiation. In contrast, the gene expression of other matrix proteins remained similar 
(Fig. 12 D-F). There was no significant difference for COL I or COL III between the tECM and 
the pure collagen group. The expression of COL I in 3D culture was lower than that in 2D, which 
could be attributed to the collagen rich environment. DCR was up-regulated in 3D cultures at all 
time points, with expression in the tECM group lower than the collagen group at day 7.  
To evaluate the influence of tECM on osteogenic differentiation, the expression of 
osteogenesis markers, including RUNX 2, ALP and OCN (Fig. 12 G-I), was analyzed. At days 1 
and 3, the level of RUNX2 gene expression in hASCs in the tECM group was significantly lower 
than that of the pure collagen group. hASCs in the tECM group also expressed lower amount of 
ALP and OCN than in pure collagen at days 3 and 7. Taken together, these results suggested that 







 Figure 12. Real time PCR analysis of gene expression. (A-C) hASCs seeded in tECM-supplemented 
scaffolds (3D Collagen+ECM) show higher expression levels of tendon-specific genes (SCX, TNMD, and TNC) 
compared to both pure collagen scaffolds (3D Collagen) and 2D culture group (2D). (D) Collagen type I expression 
level in 3D culture is lower than that in 2D culture. (F) Decorin expression is up-regulated in 3D cultures throughout 
the experiment, but differs between collagen and tECM groups only at day 7. (G-I) Osteogenesis-related genes 
(RUNX2, ALP, and OCN) are expressed at lower levels in hASCs seeded in tECM-supplemented scaffolds 
compared to the pure collagen scaffold group. *,  p<0.05 compared to 2D; **, p<0.01 compared to 2D; #, p<0.05 
compared to the other 3D group; ##, p<0.01 compared to the other 3D group; n=5 
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2.4.5 Mechanical properties of the scaffold 
We tested the mechanical properties of constructs by clamping the anchor pieces of the 
plate membrane during elongation (Fig. 13 A, black arrows). A representative load/displacement 
curve for day 3 samples showed a steeper linear slope of the tECM-supplemented scaffold when 
compared with the pure collagen scaffold, indicating better resistance to deformation (Fig. 13 B). 
Maximum load of tECM-supplemented scaffold was significantly higher than that of pure 
collagen scaffold at both time points (Fig. 13 C, n=5, p<0.05). The stiffness of tECM-
supplemented scaffolds was 2.37 and 4.11 times that of the pure collagen scaffolds at days 3 and 
7, respectively (Fig. 13 D, p<0.01). In summary, these results showed that the addition of tECM 
enhanced the mechanical properties of hASC-seeded scaffolds under static tension.  
 
 Figure 13. Mechanical properties of constructs. (A) At days 3 and 7, constructs were excised from the 
rubber membrane together with the anchors and fixed between two clamps (black arrows), so that the integrity of 
scaffold was not compromised by clamping.  (B) A representative load/displacement curve for day 3 samples shows 
 51 
steeper linear slope and higher failure force of the tECM-supplemented scaffold (Collagen + tECM) compared to the 
pure collagen scaffold (Collagen). (C, D) Higher maximum load (C) and stiffness (D) of tECM-supplemented 
scaffolds (Collagen+ECM) were found than that of cell seeded pure collagen scaffolds (Collagen) at each time point. 
*, p<0.05; **, p<0.01; n=5 
2.4.6 Gene expression and activity of MMPs 
Interestingly, none of the cell-seeded scaffolds demonstrated improved mechanical 
strength compared to cell free controls (data not shown). Moreover, we found little difference in 
ECM protein-encoding gene expression patterns between 3D groups. Combined, these results 
implied that the difference in mechanical properties between the cellular scaffold groups might 
be due to remodeling of the matrix rather than a net increase in matrix deposition. To test this 
hypothesis, we investigated the expression and activity of matrix metalloproteinases (MMPs), an 
endopeptidase family responsible for degradation and remodeling the ECM. Real-time PCR 
analysis revealed that gene expression level of MMPs significantly increased in 3D groups 
compared to 2D, indicating highly active matrix remodeling occurred in 3D culture under tension 
(Fig. 14 A-E, n=5). MMP-8, -9 and -13 were down-regulated in the tECM-supplemented group 
by day 3 or 7 compared to the pure collagen group (Fig. 14 C-E, p<0.01). Finally, the total 
combined MMP activities in conditioned medium collected from the tECM group was found to 






 Figure 14. Matrix metalloproteinase (MMP) expression and activity. (A-E) hASCs seeded in 3D scaffolds 
expressed significantly higher amounts of MMPs compared to 2D culture group. (C-E) Expression levels of MMP-8, 
-9 and -13 were down-regulated in the tECM group (3D Collagen+ECM) compared to the collagen group (3D 
Collagen). (F) MMP activity in conditioned medium collected from the tECM group (3D Collagen+ECM) was 
significantly lower than that of the collagen group (3D Collagen). *, p<0.05 compared to 2D; **, p<0.01 compared 
to 2D; #, p<0.05 compared to the other 3D group; and ##, p<0.01 compared to the other 3D group; n=5 
2.5 DISCUSSION 
In this chapter, we have investigated the influence of a soluble ECM extract from bovine 
tendon tissue, used as a supplement to collagen scaffold, on hASCs cultured in 3D collagen gel 
under uniaxial tension. We hypothesize that incorporation of tECM will enhance the bio-
functionality of 3D tension-bearing scaffolds. Our results show that the tECM contains a variety 
of tendon matrix proteins. The inclusion of tECM within collagen scaffolds promotes hASC 
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proliferation and tenogenic differentiation, as compared with pure collagen scaffold. Moreover, 
hASCs in tECM-containing scaffolds demonstrate reduced osteogenesis compared to hASCs in 
pure collagen scaffolds. The addition of tECM also results in changes of the mechanical 
properties of the constructs, including contraction rate, maximum load, and stiffness, partially by 
altering the expression level and activity of MMPs of the seeded hASCs. Collectively, these 
findings reveal the bio-functionality of tECM on hASC behaviors in 3D culture under tension, 
and strongly suggest the feasibility of using tECM to facilitate hASC-based tendon healing and 
regeneration.  
ASCs, a multipotent mesenchymal stem cell population derived from adipose tissues, 
possess the potential to differentiate into a variety of cell lineages [147]. As far as the 
regeneration of mesodermal tissues are concerned, ASCs can undergo adipogenic, osteogenic, 
chondrogenic [148], myogenic [149], and tenogenic differentiation [82, 86, 150]. Given their 
availability and tenogenic capacity, the use of ASCs thus expands potential approaches to tendon 
tissue engineering and tendon repair. Tenogenesis of MSCs can be induced through uniaxial 
tension in 3D culture [126, 142, 151]. In this study, we have used the Flexcell Strain Unit with 
the Tissue Train culture plates to generate 3D cylindrical constructs under tension [125]. 
Collagen type I gel was used as the material to cast the scaffold for two reasons. First, collagen 
type I is the primary component of tendon tissue, and has been widely used as a scaffold in 
tendon tissue engineering. Second, cells could be easily suspended in collagen solution before 
setting, ensuring uniform distribution within the constructs. In contrast, previous studies have 
shown that cells re-seeded on acellular tendon tissue attached only to the surface but did not 
penetrate the matrix easily. In these studies, few cells were observed to migrate into the center of 
acellular flexor tendons even after 8 weeks in culture [95, 152].  
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For the purpose of facilitating tendon healing and regeneration, MSCs need to proliferate 
and then undergo appropriate differentiation and matrix remodeling on the scaffold in order to 
develop into a functional replacement tissue at sites of injury [50], [136]. The ECM plays 
important roles in regulating cell behavior. Tissue-derived ECMs have been found to induce 
corresponding tissue-specific differentiation of MSCs, and are therefore considered as attractive 
candidate biomaterials to support stem cell-based regeneration of the tissue from which it is 
derived. For example, soluble ECM derived from skeletal muscle tissue induced myogenesis of 
muscle progenitor cells [153]. Similarly, acellular cartilage sheets were found to stimulate 
BMSCs to undergo chondrogenesis [154]. In tendon, tenocytes are surrounded primarily by 
ECM in their native microenvironment. BMSC seeded on acellular tendon scaffold expressed 
TNMD, a tendon phenotype marker [155]. Tendon-derived stem/progenitor cells (TSPCs) were 
also found to express more TNMD when seeded on tendon ECM film than on tissue culture 
plastic [123]. In this study, we have used urea, a nonionic chaotropic reagent that disrupts lipid-
lipid, lipid-protein, and protein-protein interactions, for tECM extraction, producing a soluble 
extract that is easily miscible in aqueous solutions. SDS-PAGE and western blot assay revealed 
that soluble tECM isolated from tendons contains not only collagen but also numerous non-
collagenous proteins, including fibronectin, fibromodulin, biglycan and decorin, all of which are 
known to regulate MSC behavior. For example, fibronectin is a multi-domain protein that 
contains binding sites for integrins, collagen and other ECM proteins, glycosaminoglycans, as 
well as self-association sites, thereby influencing cell shape and adhesion to the matrix [156]. 
Moreover, fibronectin has also been reported to induce chemotaxis and mitogenic activity for 
human MSCs [157]. These characteristics of fibronectin may contribute to the improved 
interaction between cells and tECM-containing scaffold, as evidenced by increased extensions 
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from the cell body connected to the collagen fibrils, and increased retention of the seeded cells 
(data not shown). Decorin greatly affects the assembly of collagen fibrils during tendon 
development [36], and also prevents aberrant lateral fusion of collagen fibrils [158]. Biglycan 
and fibromodulin appear to have substantial impacts on cell fate. BMSCs from biglycan- and 
decorin-deficient mice were unable to sequester TGF-β in ECM, resulting in a switched fate 
from growth to apoptosis [159]. Human skin fibroblasts exposed to human fibromodulin formed 
embryonic stem cell-like colonies expressing pluripotency markers including NANOG, SOX2 
and OCT4 [160]. Biglycan and fibromodulin were also identified as critical components of the 
tendon stem cell niche controlling the fate of tendon stem cells [38]. It is thus reasonable to 
hypothesize that the known activities of these ECM molecules, and of other yet-to-be-determined 
components in the tECM, are responsible for the observed bioactivity of the tECM on the hASCs 
seeded in the composite 3D scaffold.  
Our hypothesis is supported by the results of the cell proliferation assay, real-time PCR 
analysis, and mechanical testing. DNA content and cell metabolic activity are significantly 
higher in the tECM-supplemented constructs than pure collagen constructs after 7 days of 
culture, indicating more rapid proliferation in the tECM group. It is noteworthy that DNA 
content measured immediately after gel setting (defined as day 0) showed no significant 
difference between the two groups (data not shown), indicating minimal residual, tissue-derived 
nuclear remnants. Consistent with our results, rabbit TSPCs have been shown to grow faster in 
tECM than on plastic surfaces, as indicated by the population doubling times [123]. Furthermore, 
hASC cultures seeded in constructs containing ligament-derived matrix were also found to 
contain more dsDNA than in collagen constructs [122].  
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Real-time PCR analysis revealed enhanced tenogenesis of hASCs in the tECM group 
based on tendon-specific gene expression compared to tECM free groups (Fig. 12). Furthermore, 
despite the efficacy of 3D culture under tension to promote tenogenesis, simultaneous 
osteogenesis had been reported for hASCs cultured under mechanical stimulation, an undesirable 
effect that compromises the application of hASCs for tendon repair. For instance, cyclic 
mechanical loading was found to increase RUNX2 expression of rat ASCs [161, 162]. In another 
study, up-regulation of ALP and OCN expression in hASCs was achieved by 1 and 2 hour cyclic 
strain [163]. It has been suggested that such tension-induced osteogenesis is the cause of 
pathological ossification seen in mechanically overused tendon, such as in tendinosis [164]. 
Therefore, we asked whether hASCs cultured under uniaxial tension undergo osteogenesis and if 
this differentiation can be attenuated by incorporation of tECM. Our findings show that tECM 
significantly reduces osteogenic differentiation of hASCs when cultured in 3D under tension 
(Fig. 12 G-I). Based on the results reported here, we speculate that the reduced osteogenesis is 
the result of exposure to a more tenogenic niche provided by the tECM incorporated into the 3D 
scaffold, implying a tendon tissue-specificity of the pro-differentation effect of the tECM on 
hASCs. 
Since tendons are primarily load-bearing tissues, the mechanical properties of engineered 
tendons need careful consideration. In this study, we investigated the mechanical properties of 
the constructs from two perspectives: contraction rate and mechanical strength. As the cells 
reorganized and remodeled the collagen matrix, macroscopic radial contraction of the construct 
was evident (Fig. 9). Similar to our results, constructs made from collagen type I gel seeded by 
BMSCs at 1 million cells/mL were found to contract by 61% of its initial diameter after 3 days 
[142]. In another study, the contraction rate peaked 1 day after gel setting with 82% reduction of 
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the cross-sectional area of the construct after 8 days [125]. To our knowledge, this study is the 
first to provide quantitative data for the effect of tECM on the contraction rate of cell-seeded 
collagen gels. In addition, tECM-supplemented constructs demonstrates improved mechanical 
strength, evidenced by significantly higher maximum load and stiffness of the constructs. Greater 
scaffold stiffness may result in greater tactile forces placed upon the encapsulated cells during 
contraction, causing tenogenic differentiation through the induction of SCX expression, which is 
known to be responsive to change in mechanical stimulus [165, 166]. 
Interestingly, we have observed no increase in mechanical properties of each type of cell-
seeded scaffold compared to cell-free scaffolds. This observation, combined with the finding that 
there was little difference in ECM protein gene expression between 3D groups, ruled out the 
contribution of neo-matrix deposition. Therefore, we hypothesized that the change in mechanical 
properties was due to cell-mediated remodeling of the scaffold. To test this hypothesis, we 
investigated the expression and activity of MMPs, endopeptidases capable of degrading and 
remodeling extracellular matrix [167]. Due to their matrix degrading capability, MMPs are 
involved in the degradation of a number of collagenous scaffolds. Real-time PCR analysis 
revealed a dramatic up-regulation of the expression of MMPs in hASCs seeded in the 3D culture 
under tension compared to 2D culture. Similar to our results, a significant up-regulation of 
MMP-1 and -13 expression was observed after 14 days of culture, when BMSCs were seeded on 
collagen type I gels [168]. In the same study, MMP-2 was found only activated in cells cultivated 
in collagen gels. In addition to studies of in vitro models, the alteration of MMP expression has 
been widely observed in a variety of tendon injuries in vivo [55]. For example, increased 
expression of MMP-1 and -9 was found in supraspinatus tendons in the defect group in a patient 
study [169]. MMP-2, -9 and -13 were up-regulated in ruptured human Achilles tendons [170, 
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171]. Similarly, there was a significant increase in MMP-13 mRNA in rotator cuff tendon tissue 
obtained from patients with rotator cuff tears [172]. MMP-9 and 13 were also found to 
participate in collagen degradation but not remodeling in a rat flexor tendon laceration model 
[56]. In our study, MMP-8, -9 and -13 are down-regulated by nearly 50% in the tECM group 
compared to the pure collagen group at day 7. The total MMP activity in the culture-conditioned 
medium was also significantly lower at day 3 and day 7 in the tECM group. These findings 
therefore suggest the possible influence of tECM on suppressing MMP-mediated scaffold 
degradation, which could contribute to the improvement of tendon healing.      
2.6 CONCLUSIONS 
A bioactive, soluble fraction of tendon-derived extracellular matrix (tECM) was extracted 
with urea. Exposure to tECM greatly promoted human adipose stem cell (hASC) proliferation 
and tenogenic differentiation in 3D collagen gels under static tension. hASCs in tECM-
containing scaffolds also demonstrated suppressed osteogenesis compared to hASCs in pure 
collagen scaffolds. Furthermore, the addition of tECM improved the mechanical properties of the 
constructs, in part by altering the amount of MMPs expressed by seeded hASCs and their activity 
in culture medium. These findings suggest a new approach to inducing hASC tenogenesis that 






3.0 TENDON-DERIVED EXTRACELLULAR MATRIX ENHANCES TGF-ΒETA 3 
INDUCED TENOGENIC DIFFERENTIATION OF HUMAN ADIPOSE-DERIVED 
STEM CELLS 
3.1 ABSTRACT 
Because of the limited and unsatisfactory outcomes of clinical tendon repair, tissue 
engineering approaches using adult mesenchymal stem cells (MSCs) are being considered as a 
promising alternative strategy to heal tendon injuries. Successful and functional tendon tissue 
engineering depends on harnessing the biochemical cues presented by the native tendon 
extracellular matrix (ECM) and the embedded tissue-specific bio-factors. In this chapter, we 
have prepared and characterized the biological activities of a soluble extract of decellularized 
tendon ECM (tECM) on adult adipose derived stem cells (ASCs), on the basis of histological, 
biochemical, and gene expression analyses. The results showed that tECM enhances the 
proliferation and TGF-β3 induced tenogenesis of ASCs in both 2- and 3-dimensional (2D and 
3D) cultures in vitro, and modulates matrix deposition and organization of ASCs seeded in 3D 
scaffolds. These findings suggest the utility of reproducing the native tissue microenvironment as 
a design principle to elicit desired cellular responses for tissue regeneration, and that combining 
tissue-specific ECM with growth factor treatment is an effective approach to induce robust 
tenogenesis for ASCs. 
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3.2 INTRODUCTION 
Tendon injuries occur frequently in sports and daily activities due to excessive load or 
overuse. In the U.S. alone, around 45% of the 32 million musculoskeletal injuries each year 
involve tendon, ligament and joint capsule, in which tendon injuries are especially common and 
require over 120,000 surgical repairs annually [71]. Unfortunately, the natural healing process of 
tendons is slow and insufficient, resulting in fibrotic scar formation and inferior mechanical 
strength at the injured sites [21]. Current clinical outcomes of tendon repair remain 
unsatisfactory due to limitations including autograft donor site morbidity, risk of injury 
recurrence and limited long-term function recovery [73, 74, 173]. Therefore, tissue engineering 
approaches, which use a combination of cells, scaffolds and bioactive molecules, are gaining 
increasing research interest as a promising alternative strategy to treat tendon injuries.    
The use of adult mesenchymal stem cells (MSCs) as the cellular component for tendon 
tissue engineering has been increasingly explored in recent years [38, 85, 86, 174]. Compared 
with other cell sources, adipose-derived mesenchymal stem cells (ASCs) are abundant and can 
be isolated by minimally invasive approaches [148, 175]. However, although a variety of growth 
factors are able to induce expression of tenogenic markers in ASCs, no single growth factor has 
been found to exclusively promote tenogenic differentiation. Rather, growth factors interact with 
the evolving microenvironment produced by progenitor cells to induce proliferation and tissue-
specific differentiation during development or tissue repair. In terms of tendon tissue, the 
biochemical and biophysical cues of tendon microenvironment may modulate growth factor 
bioactivity to promote tendon-specific effects that enhance the efficacy of cell therapies in 
restoring the native structure and function of tendon following injury [15, 38, 176].   
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Studies in tendon development have revealed the complexity of tendon differentiation. As 
shown across several animal models, members of the transforming growth factor-β (TGF-β) 
superfamily are actively involved in tendon development and healing in a spatiotemporally 
specific manner. For example, mouse patellar tendon cells were found to respond to TGF-β 
signaling at developmental stages starting at gestation day 17.5 and ending at postnatal day 14 
[13]. Consistent with this finding, micromass culture of chick embryonic limb bud mesodermal 
cells with TGF-β demonstrated significant up-regulation of tendon markers, scleraxis (SCX) and 
tenomodulin (TNMD), with concurrent reduction in cartilage markers [15]. Conversely, 
disruption of TGF-β signaling resulted in the loss of most tendons and ligaments in a SCX-GFP 
mouse model [14]. When injured, high levels of TGF-β expression and activity were seen 
throughout the healing period [51, 177, 178]. However, TGF-β signaling is also known to play a 
crucial role in chondrogenesis [179]. As is increasingly recognized, the tissue-specific bioactivity 
of TGF-β depends upon additional cues provided by the extracellular microenvironment [15, 
159].  
Concurrently, recent research has illustrated the pivotal role of the extracellular matrix 
(ECM) in tendon differentiation [38, 180]. ECM is composed of the structural and signal 
molecules secreted by the resident cells of each tissue. While the ECM of most tissues share 
highly conserved structural proteins (e.g., collagen, proteoglycans), it is the unique biophysical 
arrangement of these proteins, and the highly orchestrated deposition and presentation of soluble 
cues that serve to promote and maintain a particular cell phenotype [181, 182]. Tendon is rich in 
ECM components, and many of the tendon ECM proteins and growth factors embedded within 
the ECM network appear to be retained in decellularized tendons [146, 183]. As proof, tendon-
derived stem/progenitor cells (TSPCs) seeded on decellularized tendon/ligament ECM 
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demonstrated improved proliferation and tendon cell phenotype, indicating the role of tendon 
ECM in regulating proliferation and differentiation [184]. Taken together, it is reasonable to 
assume that the presence of native tendon ECM may be beneficial to TGF-β induced tenogenic 
differentiation of MSCs for tendon repair.  
In addition to biochemical cues, scaffolds are also utilized in tendon tissue engineering to 
provide mechanical support as well as three-dimensional (3D) environment that mimics the 
architecture of native tendon. Because tendon is primarily composed of aligned collagen fibers, 
scaffold anisotropy is an important topographical characteristic to consider in tendon tissue 
engineering. Cell growth and matrix deposition were found to align along the direction of 
electrospun nanofibers in a scaffold designed for rotator cuff repair [107]. Likewise, TSPCs 
seeded on aligned nanofibrous scaffolds demonstrated increased tenogenesis and collagen 
deposition, together with suppressed osteogenesis [104]. In this study, we have therefore 
prepared and employed aligned poly--caprolactone (PCL) scaffolds to reproduce the 
biophysical cues of native tendon ECM. 
The objective of this study is to investigate the effect of native tendon ECM components 
and TGF-β on the tenogenesis of human ASCs (hASC). A soluble extract of decellularized 
tendon ECM (tECM) was prepared as described in the previous chapter [183]. The individual 
and combined effects of tECM and TGF-β3 on hASC behavior, including proliferation and 
differentiation, were analyzed by using tECM as a medium supplement for cell culture with or 
without TGF-β3 for up to 2 weeks in 2D, and by ASCs seeded on 3D aligned PCL scaffolds. We 
hypothesize that tECM is able to enhance the proliferation and TGF-β3 induced tenogenesis of 
ASCs in both 2D and 3D culture in vitro, and that tECM modulates matrix deposition and 
organization of ASCs in 3D scaffolds.     
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3.3 MATERIALS AND METHODS 
3.3.1 Cell isolation and culture 
hASCs were obtained from lipoaspirate-derived fat tissue of two donors (34 years old 
male and 38 years old female) using an automated cell isolation system (Tissue Genesis Inc.), 
with University of Pittsburgh Institutional Review Board approval. Isolated hASCs were cultured 
in growth medium (GM) consisting of DMEM-high glucose (Gibco), 10% fetal bovine serum 
(FBS), and penicillin/streptomycin (P/S). hASCs between passage 2 and 4 (P2-P4) were used for 
experiments.  
3.3.2 Colony forming unit-fibroblast assay 
The colony forming unit-fibroblast (CFU-F) assay was performed using an established 
method described elsewhere [179]. hASCs from each donor at P2 were plated separately in 100 
mm dishes (Falcon) in triplicate at densities of 100 cells per dish and cultured in GM for 2 
weeks. The cultures were stained with 0.5% crystal violet solution in methanol and visible 
colonies scored.  
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3.3.3 Flow cytometry 
hASCs at P2 were detached by trypsin-EDTA and incubated with propidium iodide (PI) 
and PE- or FITC-conjugated mouse (IgG1, κ) anti-human antibodies for 30 min at 4 C°. 
Antibodies include mouse anti-human CD31, CD34, CD44, CD45, CD73, CD90, CD105 (BD 
Biosciences). Dead cells were excluded by positive PI staining. PE- or FITC-conjugated isotype-
matched IgGs (BD Biosciences) were used as controls. After washing, the cells were sorted 
using the FACSAria II SORP flow cytometer (BD Biosciences), and data analyzed with DiVa v6 
software.  
3.3.4 Preparation of tendon ECM 
A soluble fraction of tendon ECM (tECM) was prepared using our previously reported 
protocol.[183] Bovine Achilles tendons were harvested from juvenile bovine hind legs (Research 
87), pulverized, and decellularized by 1% Triton X-100 (Sigma-Aldrich). After nuclease 
treatment (200 U/ml DNase, Worthington), the acellular tissue was extracted in 3 M urea 
(Sigma-Aldrich) for 3 days. Urea was removed by dialysis in 3,500 MWCO cassettes (Thermo 
Scientific) against water for 2 days, and then the tECM extract was spin-concentrated, sterilized 
using 0.25 m PVDF syringe filter units (Millipore), and stored as 1 mg/ml stock at -20 C until 
use. 
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3.3.5 Preparation of scaffold 
Microfibers were fabricated by electrospinning. A solution of PCL (MW = 70k-90k, 
Sigma-Aldrich) prepared at 18% w/v in 1:1 (v/v) dimethylformamide (DMF) and 
tetrahydrofuran (THF) (Fisher Scientific) was extruded at 2 mL/h through a 22-gauge blunt-tip 
needle charged by 10 kV DC potential (Gamma High Voltage) and fibers collected on a custom-
designed rotating mandrel. Scaffolds were cut into 20 mm x 5 mm rectangular pieces, rehydrated 
in ethanol, and then soaked in GM overnight before cell seeding.  
3.3.6 Scanning electron microscopy (SEM) 
Scaffolds were dried in vacuum, mounted on aluminum stubs, sputter-coated with 3.5 nm 
gold, and examined by a scanning electron microscope (field emission, JEOL JSM6335F) 
operated at 3 kV accelerating voltage and 8 mm working distance. The external surface of the 
central part of the constructs was selected for imaging.  
3.3.7 Differentiation of hASCs 
Differentiation along mesenchymal lineages, including osteogenesis, adipogenesis and 
chondrogenesis, was performed to assess the multipotency of the isolated hASCs using 
established protocol with slight modifications [179]. Osteogenesis was induced by using DMEM 
supplemented with 10% FBS, 10 mM β-glycerophosphate, 0.1 µM dexamethasone and 50 µg/ml 
ascorbate for 14 days. Adipogenesis was accomplished by treatment with DMEM supplemented 
with 10% FBS, 1 µM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and 1x insulin-
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transferrin-selenium (ITS) for 14 days. Control cultures were maintained without osteogenic or 
adipogenic supplements, respectively. Chondrogenesis of high-density pellet cultures (2.5×105 
cells/pellet) was induced in serum-free DMEM supplemented with 0.1 µM dexamethasone, 40 
µg/ml L-proline, 50 µg/ml ascorbate, and 1x ITS. Recombinant human transforming growth 
factor-β1 (TGF-β1; R&D Systems, Minneapolis, MN) and bone morphogenetic protein 6 (BMP-
6, R&D Systems) was also added to the chondrogenic medium at a final concentration of 10 
ng/ml. Control pellet cultures were maintained without the addition of growth factors. For all 
groups the medium was changed every 3 days.  
To induce tenogenesis, hASCs at P3 were serum-starved overnight at a density of 1×104 
cells/cm2 in 2D culture and at 6×104 cells/cm2 in 3D culture. Cells were then treated with or 
without 10 ng/ml TGF-β3 (PeproTech) in basal medium (BM) consisting of DMEM, 1x ITS and 
P/S supplemented with 10% v/v of 1 mg/ml tECM, 1 mg/ml collagen type I solution (Col I, 
PureCol Advanced Biomatrix) or FBS for up to 14 days.  
3.3.8 Cell proliferation tests 
hASCs at P3 were plated on 2D culture plastic and 3D scaffolds at a density of 0.5×104 
cells/cm2 and 4×104 cells/cm2, respectively. Twenty-four hours after initial seeding, cells were 
fed with BM containing one of the following supplements at 10% v/v: 1 mg/ml tECM, 1 mg/ml 
Col I solution, or FBS. DMEM supplemented with 10% v/v Hanks’ Balanced Salt Solution 
(HBSS, Gibco) was used as a negative control. On days 0, 3 and 7, MTS assay (CellTiter 96 
Assay, Promega) was performed to spectrophotometrically determine metabolic activity of cells 
from each group.  
 67 
3.3.9 Real-time PCR analysis of gene expression  
Total cellular RNA was isolated (Rneasy, Qiagen) and first-strand cDNA synthesized 
using SuperScript III First-Strand cDNA synthesis kit (Invitrogen). Real-time PCR was 
performed using SYBR green Supermix in a Step One Plus real-time PCR system (Applied 
Biosystem, Life Technologies). The targets and sequences of primers are shown in Table 4. 
Relative expression level of each gene was normalized to that of 18S rRNA and calculated using 
the -Ct method.  
Table 4. Primer sequences of genes analyzed by real-time PCR 
3.3.10 Protein extraction and Western blot assay 
Eight days after differentiation induction, total protein was extracted from each group by 
TM buffer (Total Protein Extraction Kit, Millipore). Equal loads of reduced protein samples of 
the same concentration were electrophoretically separated in NuPAGE Bis-Tris Mini Gel (Life 
Technologies), and transferred onto PVDF membranes (iBlot dry blotting system, Invitrogen) for 
incubation with rabbit anti-scleraxis (SCX) or anti-glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) primary antibody (Abcam) at 4˚C overnight. Western blots were developed using 
Gene Primer sequence (5’-3’) Product size (bp) 
18S rRNA Forward GTAACCCGTTGAACCCCATT 151 
 
Reverse CCATCCAATCGGTAGTAGCG  
SCX Forward ACACCCAGCCCAAACAGA 65 
 
Reverse GCGGTCCTTGCTCAACTTTC  
TNC Forward GGTGGATGGATTGTGTTCCTGAGA 328 
 Reverse CTGTGTCCTTGTCAAAGGTGGAGA  
SOX9 Forward CTGTAGGCGATCTGTTGGGG 85 
 Reverse AGCGAACGCACATCAAGA  
COL II Forward GGATGGCTGCACGAAACATACCGG 157 
 Reverse CAAGAAGCAGACCGGCCCTAT  
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horseradish peroxidase (HRP)-conjugated donkey anti-rabbit IgG secondary antibodies (GE 
Healthcare Bio-Sciences) and West Dura Extended Duration Substrate (Thermo Scientific). 
3.3.11 Mechanical testing 
Tensile properties of scaffolds were analyzed using the Bose 3230 mechanical tester. 
Scaffolds were securely mounted and loaded with uniaxial force applied at a displacement rate of 
0.2 mm/s until 10 mm displacement. The tensile force and the displacement were recorded, and 
tensile stress was calculated by dividing the measured force by the initial cross-sectional area of 
the scaffold. Strain was calculated by normalizing the measured displacement against the initial 
clamp-to-clamp distance (~15 mm). The slope of the linear portion of the stress–strain curve was 
calculated as Young’s modulus.  
3.3.12 Matrix deposition and characterization 
hASCs were seeded on PCL scaffolds at a density of 6×104 cells/cm2 and cultured with 
BM supplemented with either only 2% FBS or 2% FBS plus 10% tECM (v/v), in the presence of 
50 µg/mL ascorbate-2-phosphate (Sigma-Aldrich), for 3 weeks. Negative controls consisted of 
cell-free scaffolds treated under the same conditions. Collagen content in each group was 
quantified using the Chloramine T-based hydroxyproline assay.  
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3.3.13 Immunofluorescent staining  
Cell-seeded scaffolds were washed in PBS, fixed in 4% paraformaldehyde, and blocked 
with 1% bovine serum albumin (BSA) and 22.52 mg/ml glycine in PBS-T. Primary antibodies 
used included goat anti-tenomodulin (Tnmd, 1:50, sc49325 Santa Cruz), or rabbit anti-Col I 
(1:500, ab34710 Abcam), with overnight incubation at 4 °C. Alexa Fluor 488 chicken anti-goat 
or Alexa Fluor 488 goat anti-rabbit were used as secondary antibodies at 1:500 dilution (Life 
Technologies). For F-actin staining, fixed cells were permeabilized in 0.1% Triton X-100 and 
then incubated with Alexa Fluor 488 phalloidin for 30 min at room temperature (Life 
Technologies). After nuclear counterstaining with DAPI (Life Technologies), cells were imaged 
using a confocal microscope (Olympus FluoView 1000).  
3.3.14 Statistical analysis 
Data are presented as mean ± standard deviation (SD). All quantitative assays were 
performed for no less than three times independently (N equals to the number of independent 
tests in figure legends). In each replicate, cells from two donors were treated and analyzed 
separately in duplicate, and data were combined. One-way ANOVA with Bonferroni post hoc 
test and Student’s t-test was performed to determine statistical significance. Significance was 






3.4.1 Characterization of human ASCs 
The stromal vascular fraction (SVF) of adipose tissue is composed of a mixture of cell 
types, including endothelial, smooth muscle, cardiac, immune, stromal cells and ASCs (Fig. 15 
A) [185]. After 14 days of culture, 28.83 ± 3.31% of the adherent cells were found proliferating 
by CFU assay, indicating a self-renewal capability within the cell population (Fig. 15 B). Upon 
differentiation induction, the cultured cells at P2 were able to undergo differentiation toward 
multiple mesenchymal lineages, including adipogenesis, osteogenesis, and chondrogenesis (Fig. 
15 C). Moreover, the phenotypic analysis by flow cytometry suggested a relatively homogeneous 
population that expressed mesenchymal cell markers (CD44, CD73, CD90 and CD105) but was 
free of hematopoietic and endothelial markers (CD31, CD34, CD45) (Fig. 15 D) [186]. Taken 
together, these results confirmed that the cell population used for subsequent experiments 
exhibited characteristics consistent with ASCs derived from subcutaneous lipoaspirate. 
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 Figure 15. Characterization of hASCs. (A) Composition of adipose tissue, consisting of mature 
adipocytes, blood vessels and a stromal vascular fraction (SVF). (B) Crystal violet staining visualizes the colonies 
formed by proliferating cells. (C) Histological detection of ASC multipotency: Adipogenesis by Oil Red staining 
(red), osteogenesis by Alizarin Red staining (red), and chondrogenesis by Safranin-O staining (red). (D) Flow 




3.4.2 Effect of tendon ECM on ASC behavior in 2D 
In order to investigate the role of tendon ECM in regulating ASC behavior, we extracted 
the soluble fraction of decellularized tendon ECM (tECM) from juvenile bovine Achilles 
tendons. As previously reported, the tECM solution prepared by this method is cell free and rich 
in non-collagenous ECM proteins, with a constant yield rate and consistent composition (Fig. 8) 
[183]. tECM or Col I solution were used at 1 mg/ml as medium supplements at 10% v/v to treat 
ASCs on 2D tissue culture plastic for up to 7 days. ASCs cultured with HBSS-supplemented 
medium or FBS-supplemented medium (10% v/v) were used as negative and positive control, 
respectively (Fig. 16 A). At days 0, 3 and 7, cell density and metabolic activity were determined 
by DAPI staining and MTS assay. After 7 days of culture, higher cell density in tECM and FBS-
treated groups was clearly visualized by DAPI staining (Fig. 16 B). As shown in Figure 16 C, 
ASCs cultured with tECM demonstrated significantly higher metabolic activity than those with 
Col I, the most abundant structural ECM protein in tendon tissue, but slightly lower than those 
cultured with FBS.  
 
Figure 16. Assay of hASC proliferation in 2D cultures. (A) hASCs were plated on 2D tissue culture 
plastic, and treated with basal medium (BM) containing one of the following supplements at 10% v/v: HBSS, 1 
mg/ml tECM solution (tECM), 1 mg/ml collagen type I solution (Col I) or FBS. (B) After 7 days of culture, DAPI 
 73 
nuclear staining showed high cell density in tECM- and FBS-treated groups. (C) MTS assay revealed elevated 
cellular metabolic activity in tECM- and FBS-treated groups. *, p<0.05; **, p<0.01; N=3 
 
The individual and combined effect of tECM and TGF-β3 on hASC tenogenesis was 
analyzed at the mRNA and protein level. Three types of medium (BM supplemented with 10% 
v/v FBS, Col I, or tECM) were prepared, with or without 10 ng/ml TGF-β3, in which ASCs were 
cultured for up to 14 days (Fig. 17 A). Real-time PCR analysis showed that treatment with tECM 
alone did not significantly increase the expression of SCX, the primary marker for early tendon 
differentiation. However, tECM combined with TGF-β3 gave rise to significantly higher levels 
of SCX expression than all other groups tested at days 3 and 7 that were maintained after two 
weeks of culture. ASCs treated with TGF-β3 in the presence of Col I showed lower levels of 
SCX expression on days 3 and 7 compared to the tECM plus TGF-β3 treatment (Fig. 17 B). The 
difference in SCX expression among the groups was confirmed at the protein level by Western 
blot (Fig. 17 D). Interestingly, unlike SCX, TNC expression was up-regulated by tECM 
treatment in the absence of TGF-β3 after 7 and 14 days of culture, while the combined treatment 
of tECM and TGF-β3 led to the highest level of TNC mRNA among all groups (Fig. 17 C). 
ASCs treated with TGF-β3 in the presence of Col I again showed delayed up-regulation of 
tendon marker compared to the tECM plus TGF-β3 treatment (Fig. 17 C). Taken together, these 
data showed that tECM treatment in 2D resulted in partial adoption of the tendon cell phenotype 
in the absence of other inductive cues, and further enhanced tenogenesis of ASCs induced by 
TGF-β3. Moreover, tECM exhibited no such inductive effect on chondrogenesis of ASCs in 2D 





 Figure 17. Tenogenesis of hASCs in 2D cultures. (A) Experiment groups. (B, C) Real-time PCR analysis 
of scleraxis (SCX, B) and tenascin-C (TNC, C) expression levels suggested that tECM treatment up-regulated SCX 
expression in the presence of TGF-β3, and increased TNC expression with or without TGF-β3. (D) Western blot 
assay showed consistent difference in SCX protein. *, p<0.05; **, p<0.01; N=3 
 
 Figure 18. Real-time PCR analysis of SOX9 expression revealed that tECM alone possessed little 
inductive effect on chondrogenesis of ASCs in 2D culture compared to cell pellets cultured in standard 
chondrogenic medium (Chondro Medium). **, p<0.01; N=3 
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3.4.3 Characterization of the aligned microfiber scaffolds 
We next attempted to generate a physical scaffold environment that mimics the structural 
feature of tendon. A 3D microfibrous PCL scaffold was fabricated by electrospinning. Aligned 
scaffolds exhibited highly uniaxial fiber orientation: most fibers were oriented at between 80° 
and 100° with respect to cross axis (Fig. 19 A, B), in contrast to the random orientation seen in 
the non-aligned scaffolds (Fig. 19 C, D). No significant difference in fiber diameter was found 
between aligned and random scaffold (1.26 ± 0.51 µm vs. 1.29 ± 0.34 µm).  When tension was 
applied in the direction of fiber alignment, the aligned scaffolds displayed 2.5-fold higher tensile 
strength as compared to the randomly oriented scaffolds (Fig. 20 A, B). Anisotropy of the 
aligned scaffold was confirmed by tensile testing along two planes: the elastic modulus along the 
axis of fibers (longitudinal) was 10-fold higher than that in the perpendicular direction (cross) 
(Fig. 20 A, B). hASCs seeded on aligned scaffolds adopted elongated morphology and were 
orientated in the direction of fibers after 3 days of culture. In contrast, hASCs seeded on random 
scaffolds exhibited polygonal shape without uniformity in orientation (Fig. 21). 
 
 Figure 19. Characterization of PCL scaffold. (A, C) SEM image of aligned and random microfibrous PCL 
scaffolds. (B) Most fibers in the aligned scaffold were oriented at between 80° and 100° with respect to cross axis, 
whereas in non-aligned scaffold (D), fibers were evenly distributed in all directions.  
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Figure 20. Characterization of PCL scaffold (continued). (A) Strain-stress curves showed substantial 
difference in tensile strength between aligned and random scaffolds. Anisotropy in tensile strength was noticed in 
aligned scaffolds (Aligned longi vs. Aligned cross). (B) The elastic modulus was the highest in longitudinal 
direction (Aligned longi) in aligned scaffolds. *, p<0.05; N=3 
  
 
Figure 21. Morphology of ASCs cultured on scaffolds. ASCs seeded on aligned scaffolds adopted an 
elongated morphology and were orientated in the direction of the fibers (left, confocal microscopy; F-actin, green; 
nuclei, blue; microfiber, red). In contrast, ASCs seeded on random scaffold exhibited polygonal shape without 
uniformity in orientation (right).   
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3.4.4 Effect of tendon ECM on ASC behavior in 3D scaffolds 
ASCs seeded on aligned scaffolds were treated for one week in BM supplemented with 
10% v/v FBS, Col I, or tECM. No observable difference in cell shape was found among groups: 
most ASCs cultured on the aligned scaffolds were elongated and aligned in the direction of the 
surrounding fibers regardless of treatment method, as indicated by immunofluorescent staining 
of F-actin (Fig. 22 A). Nevertheless, cell metabolic activity differed greatly among groups: the 
tECM-treated group exhibited enhanced metabolic activity compared to Col I- or HBSS-treated 
group. At day 7, the metabolic activity of tECM-treated cells remained significantly higher than 
Col I- or HBSS-treated cells, and was comparable to FBS-treated cells (Fig. 22 B).  
 
 Figure 22. Behavior of hASCs seeded on aligned scaffolds. Cultures were treated with basal medium 
(BM) containing 10% v/v FBS, Col I, or tECM. (A) After 3 days of culture, most ASCs cultured on aligned 
scaffolds were elongated and aligned regardless of treatment methods. F-actin, green; nuclei, blue. (B) MTS assay 
showed enhanced cellular activity in the tECM-treated group compared to Col I- or HBSS-treated groups. *, p<0.05; 
N=3 
 
Given the established positive influence of fiber alignment on tenogenic differentiation, 
analysis of gene expression and matrix deposition were only performed on aligned microfibrous 
scaffolds. When cultured in BM with TGF-β3 and 2% FBS, SCX expression in hASCs was 
increased by the presence of tECM on days 3, 7 and 14, whereas in the Col I group the up-
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regulation in SCX was not seen until day 14 (Fig. 23 A, SCX). Similarly, tECM supplementation 
resulted in significantly higher TNC levels compared to controls at all three time points tested. In 
contrast, Col I treatment did not significantly up-regulate TNC level although there was a trend 
of increase (Fig. 23 A, TNC). To further investigate the extent of tECM-mediated tenogenesis, 
we analyzed the presence of Tnmd, a tendon-specific membrane glycoprotein found in the late 
phase of differentiation, by immunofluorescent staining. Compared to other treatment groups, an 
evidently higher density and intensity of staining for Tnmd (green) was seen in the tECM-treated 
group (Fig. 23 B).  
 
Figure 23. Tenogenic differentiation of hASCs seeded on aligned scaffolds. (A) Real-time PCR assay 
showed that scleraxis (SCX) and tenascin C (TNC) expression was significantly increased in the presence of tECM. 
(B) Immunofluorescence showed that staining for tenomodulin (Tnmd) was denser and more intense (green) in 
tECM-treated group. *, p<0.05; **, p<0.01; N=4 
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We next examined the influence of tECM on the synthesis and organization of collagen, 
the primary structural protein of tendon tissue. Cells seeded on PCL scaffolds were treated with 
L-ascorbate 2-phosphate for 3 weeks to accelerate ECM synthesis. Immunofluorescent staining 
of collagen type I on scaffolds surface confirmed the presence of newly-synthesized collagen 
fibrils extended in the direction of the PCL fibers in both groups. Denser collagen fibrils were 
found on scaffolds treated with tECM, while the amount of collagen presented by tECM alone on 
the acellular scaffolds was negligible (Fig. 24 A). The observed difference in collagen content 
was confirmed quantitatively by hydroxyproline assay (Fig. 24 B). In the presence of tECM, 
hASCs produced a 2.4-fold higher amount of collagen per scaffold than controls (86.54 ± 7.46 
vs. 36.79 ± 2.49 µg/scaffold). This pattern persisted when collagen content was normalized 
against double stranded DNA (dsDNA) content, with a 1.8-fold higher collagen content per unit 
weight of dsDNA (145.05 ± 17.46 vs. 80.02 ± 17.77 µg/µg DNA) in the tECM-treated group.  
 
 Figure 24. Matrix deposition by ASCs cultured on aligned scaffolds. (A) Immunofluorescent staining for 
collagen type I (green) found denser collagen fibrils deposited by cells treated with tECM compared to tECM free 
group. (B) Hydroxyproline assay showed higher collagen content in the tECM-treated group. Collagen content of 
each group was normalized to that of the corresponding cell-free group. **, p<0.01; N=3 
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3.5 DISCUSSION 
The goal of this study IS to investigate the modulatory effect of soluble tendon ECM 
(tECM) on known biochemical (i.e. TGF-β3) and biophysical cues that promote tendon 
differentiation, in order to advance the development of functional engineered tendon grafts. 
Human ASCs were prepared and characterized, and individual and combined effects of tECM 
and TGF-β3 on cell behavior, including proliferation and differentiation, were examined. We 
found that: (1) tECM enhanced TGF-β3-induced tenogenesis of hASCs in both 2D and 3D 
culture, and (2) tECM favorably modulated matrix deposition and organization by hASC-seeded 
microfibrous scaffolds. 
In the native tendon microenvironment, dense ECM surrounds the tendon cell. Tendon 
stem/progenitor cells (TSPCs) exhibited impaired proliferative and tenogenic potential in the 
absence of critical ECM proteins [38], and showed reduced TNMD expression when seeded on 
tissue culture plastic than on tendon ECM [123]. The tECM prepared in our study increased 
hASC proliferation and TNC expression when used as a culture supplement in the absence of 
other inductive cues. Expression of both TNC and SCX was further enhanced when treated 
concomitantly with TGF-β3, as shown in both 2D and 3D cultures. Our findings indicate that the 
regulatory effects of tECM on tendon cell behavior also apply to ASCs. Consistent with our 
results, Little et al. [122] found increased proliferation and partial adoption of tendon phenotype 
by ASCs seeded on acellular tendon/ligament matrix. The tECM contains not only collagen but 
also a number of non-collagenous proteins, including fibronectin, fibromodulin, biglycan and 
decorin, all of which are known to regulate MSC activities, such as adhesion, proliferation, 
stemness and differentiation [156, 157, 159, 160]. How these ECM molecules, along with other 
yet-to-be-determined components in the tECM, contribute to the bioactivity of the tECM in our 
 81 
results remains to be investigated. The enhancement of ASC tenogenesis by tECM combined 
with TGF-β3 treatment exemplifies the complexity in the fine control of tissue differentiation: 
the tECM may serve as a reservoir of signals by itself or, not mutually exclusively, exert a 
regulatory effect on exogenous inductive cues [159]. Moreover, we found little inductive effect 
of tECM on chondrogenesis. Substantially lower SOX9 expression in 2D culture of ASCs treated 
with TGF-β3 in BM, regardless of medium supplement, was found when compared to standard 
chondrogenic treatment for pellet culture. This finding further highlights the tissue specificity of 
the derivation of ECM in influencing MSC differentiation. 
To date, ASCs are widely used for scaffold repopulation and as a means to improve 
vascularization, matrix deposition, and implant integration [187-190], whereas optimization of 
tendon-specific differentiation of seeded ASCs remains elusive. On one hand, ASCs isolated 
from a variety of animal species have been reported to upregulate tenogenic markers in vitro 
under specific treatment [85-88, 176], suggesting the tenogenic potential of ASCs. On the other 
hand, Eagan et al. questioned the suitability of hASCs for tendon tissue engineering and reported 
the lack of any significant and consistent up-regulation in the expression of COL I, TNC, or 
SCX, in hASCs treated for up to 4 weeks with TGF-β1 or IGF1 [191]. In addition, hASCs 
showed lower SCX expression compared to TSPCs when cultured in vitro [90]. Incorporating 
tissue-specific ECM molecules into differentiation protocols represents an alternative approach 
to develop a robust tenogenesis strategy for ASCs in order to better exploit the regenerative 
potential of ASCs applied to tendon tissue engineering.     
As noted above, the scaffold is another key component in tendon tissue engineering by 
creating a 3D environment for mechanical support and tissue regeneration. Therefore we 
prepared electrospun, aligned fibrous PCL scaffolds consisting of microfibers (~1.3 µm) to 
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simulate the size of collagen fibrils in natural tendon tissue (1-300 µm) [192]. The diameter of 
fibers has been found to have an influence on seeded cells: compared with nanofibers, 
microfibers promoted the expression of phenotypic markers of tendon fibroblasts, possibly due 
to the resemblance of the healthy, mature matrix with micron-sized collagen bundles [193, 194]. 
The aligned scaffold also demonstrated anisotropy similar to that of tendon tissue, but 
improvements in tensile strength (~26 MPa) is clearly needed if intended to be used as a clinical 
tendon graft (~550 MPa) [195].  
We examined the influence of tECM on collagen synthesis and organization by hASCs 
seeded on aligned scaffolds. Consistent with previous studies, collagen fibrils were aligned in the 
direction of the PCL fibers [196]. More abundant and homogenous distribution of collagen fibrils 
were found in cells treated with tECM. The tECM-induced enhancement of collagen 
fibrillogenesis may be due to the bioactivity of small leucine-rich proteoglycans (SLRPs) and 
glycoproteins in tECM, such as decorin, biglycan, lumican and collagen oligomeric matrix 
protein. These proteins are able to bind non-covalently to collagen molecules at specific sites in 
the gap region of fibrils and therefore facilitate collagen fibrillogenesis and stabilization [36, 37, 
39, 40]. Acellular scaffolds possessed negligible collagen content when treated with tECM. This 
confirms that the tECM acts by promoting collagen production in ASCs rather than by merely 




In this study, a bioactive, soluble fraction of tendon ECM (tECM) was prepared, 
characterized and incorporated into growth/differentiation medium to treat ASCs. We 
demonstrated that tECM treatment enhanced the proliferation and tenogenic capacity of hASCs 
in both 2D and 3D culture. Moreover, when cultured on scaffolds that mimic the mechanical 
properties and architecture of native tendon tissue, hASCs treated with tECM exhibited increased 
Col I matrix synthesis and improved organization. These findings provide new insights into the 
role of tissue-specific ECM in guiding site-appropriate cell responses in terms of connective 
tissue differentiation and healing. In addition to serving as an in vitro differentiation model, the 
design attributes of the 3D culture system developed in this study are applicable to functional 
tendon tissue engineering that aims at simultaneous induction of phenotypic markers and 
enhanced matrix deposition. Our findings highlight the importance of reproducing the native 












4.0 MULTILAYERED POLYCAPROLACTONE/GELATIN FIBER-HYDROGEL 
COMPOSITE FOR TENDON TISSUE ENGINEERING 
4.1 ABSTRACT 
Regeneration of injured tendon and ligament (T&L) remains a clinical challenge due to 
their poor intrinsic healing capacity. Tissue engineering provides a promising alternative 
treatment approach to facilitate T&L healing and regeneration. Successful tendon tissue 
engineering requires the use of three-dimensional (3D) biomimetic scaffolds that possess the 
physical and biochemical features of native tendon tissue. We report here the development and 
characterization of a novel composite scaffold fabricated by co-electrospinning of poly-ε-
caprolactone (PCL) and methacrylated gelatin (mGLT). We found that photocrosslinking 
retained mGLT, resulted in uniform distribution of mGLT throughout the depth of scaffold and 
preserved scaffold mechanical strength. Moreover, photocrosslinking integrated stacked scaffold 
sheets to form multilayered constructs mimicking the structure of native tendon tissues. Cells 
impregnated into the constructs remained responsive to topographical cues and exogenous 
tenogenic factors such as TGF-β3. The excellent biocompatibility and highly integrated structure 
of the scaffold developed in this study will allow the creation of more advanced tendon graft that 
recapitulates the architecture and cell phenotype of native tendon tissues.  
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4.2 INTRODUCTION 
Tendons and ligaments are prone to injuries such as rupture and laceration due to their 
load-bearing nature [71, 135]. In cases of severe tendon injury, surgical intervention is employed 
to repair or replace the damaged tendon with autografts, allografts, xenografts, or prosthetic 
devices [197-199], for the natural healing process is slow and insufficient [23, 200]. To date, the 
clinical outcomes of tendon repair remain limited and unsatisfactory due to donor site morbidity, 
high failure rates, risk of injury recurrence, and limited long-term function restoration [72, 73, 
201]. These limitations have spurred the development of tendon tissue engineering approaches, 
which apply combination of cells, scaffolds and bioactive molecules, as a promising strategy to 
create functional tissue replacements or to enhance the innate healing process [139, 202]. 
Ultimately, tendon tissue engineering aims at improving the quality of healing in order to fully 
restore tendon structure and function [21].  
Tendon tissues are composed of densely packed aligned collagen fibrils that connect 
muscle to bone [200, 203]. Therefore, aligned nano- and micro-fibrous scaffolds fabricated by 
electrospinning have been extensively explored in attempts to reproduce the mechanical and 
topographical characteristics of native tendon tissue [104, 107, 204]. Electrospun poly--
caprolactone (PCL) scaffolds are frequently used in tendon tissue engineering as well as 
applications for other soft tissues. PCL is an aliphatic linear polyester approved by the U.S. Food 
and Drug Administration for clinical use [205]. It is biocompatible, bioresorbable and a low-cost 
synthetic polymer. Of equal importance, PCL exhibits low degradation rate due to its semi-
crystalline and hydrophobic nature [206, 207], making it a suitable graft material to facilitate the 
relatively slow healing process of injured tendons [47, 54]. However, the hydrophobic nature of 
PCL often results in poor wettability and low surface protein adsorption [208], leading to 
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inadequate cell attachment and tissue integration [209]. Moreover, as a synthetic polyester, its 
lack of bioactivity is a major challenge for PCL to direct cell behavior after seeding due to the 
absence of cell-binding motifs found in natural ECM proteins [210].  
Hydrogels prepared from collagen and its derivative, gelatin, represent another class of 
scaffolds for regenerating and repairing a wide variety of tissues and organs [211, 212]. Unlike 
other types of scaffolds, hydrogels retain a large volume of water and thus provide a highly 
hydrated environment similar to that in native tissues. Cells encapsulated within collagen/gelatin 
hydrogels can be easily distributed homogeneously by simple mixing during gel preparation 
compared to electrospun scaffolds, without any further scaffold modification [102, 183]. 
Importantly, collagen and gelatin, as constituents of natural ECM, better mimic at least in part 
the native tissue microenvironment, as compared to synthetic polymers [213, 214]. Nevertheless, 
improvement in the mechanical properties and introduction of topographical cues are needed to 
apply these hydrogels to tendon grafts that aim at reproducing the mechanical and structural 
features of native tendon tissues. 
The organization of native ECM may be viewed as a cell-containing hydrogel reinforced 
by structural fibers. An engineered scaffold consisting of hydrogels and electrospun fibers may 
thus be considered as a biomimetic of the ECM. For example, a microfiber-reinforced silk 
hydrogel displayed a greatly improved modulus compared to a fiber-free hydrogel [215]. In 
addition, hydrogels composed of natural proteins could provide the bioactive motifs absent from 
synthetic polymeric scaffolds to enhance control of cell binding and fate determination [183, 
184]. In terms of tendon tissue engineering, an ideal composite scaffold consisting of hydrogel 
and fibrous scaffold has yet to be developed. Consequently, little is known about the effects such 
a composite scaffold may have on the activities of encapsulated cells.  
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In this chapter, we have developed a novel composite scaffold as a tendon graft 
consisting of electrospun PCL microfibers and methacrylated gelatin (mGLT). We have 
optimized the retention of mGLT by photocrosslinking and its integration with the fibrous 
scaffold. Simultaneous cell seeding and photocrosslinking between scaffold layers were 
performed to create cell-impregnated multilayered constructs, and their mechanical properties 
and architecture and the activity of encapsulated cells were assessed. Our results showed that this 
novel cell-scaffold construct combines the advantages of PCL nanofibrous scaffolds and gelatin 
hydrogels to mimic the mechanical strength, structural architecture and cell phenotype of native 
tendon tissue.   
4.3 MATERIALS AND METHODS 
4.3.1 Synthesis of methacrylated gelatin 
Methacrylated gelatin (mGLT) was synthesized using an established protocol with slight 
modification [102, 216]. Gelatin (GLT, Sigma-Aldrich) was dissolved in deionized H2O at 37 °C 
(30%, w/v). Methacrylic anhydride (Sigma-Aldrich) was added dropwise into the mixture at 37 
°C under mild agitation to react with amine groups on GLT for 24 hours (Fig. 25 A). Reacted 
mGLT solution was dialyzed against water to completely remove low molecular-weight 
byproducts using 3,500 NMWCO dialysis cassettes (Thermo Scientific). Dialyzed mGLT was 
lyophilized and stored desiccated for future use. The methacrylation rate of the product was 
~80% [209]. The visible light (VL)-activated photo initiator lithium phenyl-2,4,6-
trimethylbenzoylphosphinate (LAP) was synthesized as described by Fairbanks et al. [217].  
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 Figure 25. Synthesis and crosslinking of methacrylated gelatin (mGLT). (A) The amine groups on gelatin 
molecules were reacted with methacrylic anhydride to add methacrylate pendant groups. (B) To create a hydrogel 
network, mGLT was crosslinked using VL irradiation in the presence of photoinitiator LAP. 
4.3.2 Fabrication of composite scaffolds 
Composite scaffolds containing interspersed PCL and mGLT fibers were produced using 
dual electrospinning [218]. PCL particles (70k-90k, Sigma-Aldrich) was dissolved in 2,2,2-
trifluoroethanol (TFE, Sigma-Aldrich, 18% w/v). Dehydrated mGLT was dissolved in 95% TFE 
(20% w/v). Each polymer solution was extruded through a 22-gauge blunt-tip needle at 2 mL/h 
for 1 hour. The spinnerets were charged with an optimized DC potential (8 kV for PCL and 15 
kV for mGLT, respectively) and aligned in opposing positions on each side of the collection 
mandrel with a distance of 15 cm between the needle tip and mandrel (Fig. 26). The scaffold was 
stored desiccated under vacuum to remove residual solvent. To retain mGLT in the composite 
scaffold, 0.5% LAP solution was cast onto dry composite scaffold surface at 15 µl/cm2 and 
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allowed to spread until the scaffold was completely wet. LAP was then activated by exposure to 
VL irradiation (450-490 nm) to photocrosslink the methacrylate groups of the dissolved gelatin 
in the scaffold (Fig. 25 B, Fig. 26).  
 
 Figure 26. Composite scaffold preparation. Dual electrospinning was employed to fabricate a scaffold 
containing PCL and mGLT fibers (Insert 1). Dry scaffold was wetted with aqueous photo-initiator solution (Insert 2) 
and then photocrosslinked by visible light (VL) to retain the gelatin (Insert 3). 
4.3.3 Imaging of composite scaffolds 
Polymers were fluorescently labeled to track the presence and interspersion of the two 
distinct fiber populations: PCL solution was mixed with 0.1% (v/v) Vybrant® DiI Cell-Labeling 
Solution (DiI, Life Technologies), and non-methacrylated GLT was conjugated with fluorescein 
5(6)-isothiocyanate (FITC, Sigma-Aldrich) before dissolution, respectively. Fibers were dual-
electrospun onto glass slides for 5 min and imaged before and after wetting using an Olympus 
CKX41 inverted fluorescent microscope equipped with a CCD camera. Additionally, scaffold 
surface was examined by scanning electron microscopy (SEM, field emission, JEOL JSM6335F) 
operated at 3 kV accelerating voltage and 8 mm working distance.  
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4.3.4 Histological examination of composite scaffolds 
Picrosirius red staining was employed to assess gelatin retention and distribution within 
scaffolds. Composite scaffolds before and after photocrosslinking were washed in PBS at 37 °C 
overnight under mild agitation, frozen-embedded in OCT compound (4583 Scigen Scientific), 
and cryosectioned at 15 µm thickness using a Leica CM 1850 cryotome. Sections were washed 
in PBS and stained with 0.1% sirius red in saturated picric acid (Electron Microscopy Sciences) 
for 1 hour. To visualize impregnated cells, cryosections of fixed, cell-seeded scaffolds were 
incubated with ethidium homodimer-1 (EthD-1, Life Technologies) to label cells via DNA 
binding.  
4.3.5 Biochemical composition of composite scaffolds 
Gelatin content of composite scaffolds was quantified by the Chloramine-T based 
hydroxyproline assay (Fisher Scientific and Sigma-Aldrich). Reaction product was measured 
spectrophotometrically at 550 nm using a microplate reader (BioTek). Relative gelatin retention 
rate was calculated as the reading of washed scaffold divided by that of dry scaffold. 
4.3.6 Cell isolation and culture 
Human adipose-derived stem cells (hASCs) were obtained from lipoaspirate-derived fat 
tissue of two donors (34 years old male and 38 years old female) using an automated cell 
isolation system (Tissue Genesis). The protocol was approved by the Institutional Review Board 
of the University of Pittsburgh. Isolated hASCs were cultured in growth medium (GM) 
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consisting of DMEM-high glucose (Gibco), 10% fetal bovine serum (FBS, Gibco), 100 units/ml 
penicillin and 100 mg/ml streptomycin (P/S, Gibco). Multipotency was confirmed by established 
differentiation tests [179].  
4.3.7 Creation of multilayer constructs 
Scaffold pairs were prepared by overlaying one third the area of a rectangular scaffold 
piece atop another scaffold piece of identical shape. The scaffold pair was then wetted with 
photo-initiator and crosslinked by VL irradiation (Fig. 29 A), followed by gentle washing in PBS 
at 37 °C for up to 7 days. To create multilayered structures, 5 sheets of scaffold of identical 
rectangular shape were wetted with photo-initiator solution, stacked, and exposed to VL for 1 
min on each side to crosslink adjacent scaffold layers (Fig. 29 A). For these multilayer 
constructs, photo-initiator was dissolved in 8% mGLT solution to further reinforce the 
association between scaffold layers. Sandwich constructs made from alternative layers of fibrous 
PCL and mGLT solution were also prepared and subjected to the same photocrosslink protocol. 
After 7 days of washing in PBS at 37 °C, scaffold integrity was examined by picrosirius red 
staining of orthogonal cryosections.  
4.3.8 Mechanical testing 
Tensile properties of single layer scaffold and multilayer constructs were both analyzed 
by using the Bose 3230 mechanical tester. Samples were securely mounted and loaded with 
uniaxial force applied at a displacement rate of 0.2 mm/s until 10 mm displacement. The tensile 
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force and the displacement were recorded. The slope of the linear portion of the stress–strain 
curve was calculated as the elastic modulus. 
4.3.9 Creation of a tendon-mimetic construct by multilayer scaffolds 
Aligned composite scaffolds were fabricated by dual electrospinning. hASCs were 
detached and suspended in LAP-containing 8% mGLT solution and cast onto scaffold sheets for 
hydration before VL irradiation. Multilayer constructs consisting of 5 sheets of cell seeded, 
aligned scaffolds were then prepared as described above. To induce tenogenic differentiation, 
constructs were maintained for 7 days in differentiation medium (DM) consisting of DMEM, 2% 
FBS, P/S, and 10 ng/ml TGF-β3 (PeproTech). 
4.3.10 Cell proliferation tests 
Cells encapsulated in multilayer constructs were maintained in standard GM and subject 
to MTS assay (CellTiter 96 Aqueous One Solution Cell Proliferation Assay, Promega) at 1 day 
or 7 days after initial seeding. A490 was determined spectrophotometrically using a microplate 
reader (BioTek). Double stranded DNA (dsDNA) content in each group was determined 
fluorimetrically by Picogreen assay (Quant-iT PicoGreen, Invitrogen, excitation 480 nm, 
emission 520 nm). All readings were normalized to the cell free control group at each time point. 
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4.3.11 Cytoskeleton fluorescent staining  
Cell seeded, single layer scaffold sheets were washed in PBS, fixed in 4% 
paraformaldehyde and incubated with 1% bovine serum albumin (BSA). Cells were 
permeabilized in 0.1% Triton X-100 for 5 min and then incubated with phalloidin for 30 min at 
room temperature (Alexa Fluor 488 phalloidin, Life Technologies). Lastly, cells were rinsed with 
PBS, nuclear counterstained with DAPI (Life Technologies), and imaged using a confocal 
microscope (Olympus FluoView 1000). 
4.3.12 Real-time PCR analysis  
Total cellular RNA was isolated using an RNA extraction Kit (Qiagen) and first-strand 
cDNA synthesized with random hexamer primers (SuperScript III First-Strand cDNA synthesis 
kit, Invitrogen). Quantitative real-time PCR was performed using SYBR green Supermix in a 
Step One Plus real-time PCR system (Applied Biosystem, Life Technologies) to analyze 
expression of tenogenic markers, scleraxis (SCX) and tenascin-C (TNC). The targets and 
sequences of primers are shown in Table 5. The relative level of each gene was normalized to 









Table 5. Primer sequences of genes analyzed by real-time PCR 
4.3.13 Statistical analysis 
Data are presented as mean ± standard deviation (SD). All quantitative assays were 
performed for no less than three times independently (n equals to the number of samples tested). 
One-way ANOVA with Bonferroni post hoc tests and Student’s t-test was performed to 








Gene Primer sequence (5’-3’) Product size (bp) 
18S rRNA Forward GTAACCCGTTGAACCCCATT 151 
 
Reverse CCATCCAATCGGTAGTAGCG  
SCX Forward ACACCCAGCCCAAACAGA 65 
 
Reverse GCGGTCCTTGCTCAACTTTC  
TNC Forward GGTGGATGGATTGTGTTCCTGAGA 328 
 Reverse CTGTGTCCTTGTCAAAGGTGGAGA  
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4.4 RESULTS 
4.4.1 Organization of fibers in composite scaffold 
Microscopic observation of the co-electrospun scaffold showed that the fluorescently 
labeled fibers were interspersed within the dry scaffold (Fig. 27 A, Composite Dry, PCL: red; 
mGLT: green). Hydration of the scaffold in an aqueous environment resulted in rapid dissolution 
of mGLT fibers, whereas PCL fibers remained intact (Fig. 27 A, Composite Wet, PCL: red; 
mGLT: green). SEM revealed a fraction of fibers with distinct ribbon-like morphology in 
addition to ordinary cylindrically shaped fibers in the dry composite scaffold mesh (Fig. 27 B, 
Composite Dry, indicated by arrow in insert). After hydration, the ribbon portion was no longer 
detectable; instead, adjacent fibers were found bridged or bundled by deposited sheaths (Fig. 27 
B, Composite Wet, indicated by arrows in insert). The alteration in scaffold organization is likely 
caused by the dissolution and deposition of incorporated gelatin during hydration, due to its high 
aqueous solubility. In contrast, scaffold made only of PCL showed no observable difference 
between the dry and wet state, exhibiting uniform shaped fibers without fused contacts (Fig. 27 






Figure 27. Characterization of scaffold architecture. (A) Fluorescently labeled PCL (red) and gelatin 
(green) displayed a fibrous morphology and interspersed distribution within the dry composite scaffold prepared by 
dual electrospinning (Composite Dry). Wetting of the scaffold with an aqueous solution resulted in dissolution of the 
gelatin fibers (green), whereas the PCL fibers (red) remained intact (Composite Wet). (B) SEM revealed ribbon-like 
bands in addition to predominant cylindrical fibers in composite scaffold (Composite Dry, indicated by arrow in 
insert). After wetting, adjacent fibers were bridged or wrapped with a sheath of gelatin (Composite Wet, indicated 
by arrows in insert). Unlike the composite mesh, scaffolds made of only PCL showed negligible differences in 
morphology before and after wetting (PCL Dry vs. PCL Wet). 
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4.4.2 Biochemical and mechanical analysis of composite scaffold 
Hydrated composite scaffold was exposed to LV irradiation for crosslinking of mGLT in 
the presence of photo-initiator (Fig. 26). Picrosirius staining of gelatin showed a pronounced 
difference in gelatin retention between non-crosslinked and crosslinked scaffolds (Fig. 28 A). 
Without crosslinking, the scaffold displayed little red staining, indicating loss of the majority of 
incorporated gelatin after washing (Fig. 28 A, Composite non-crosslinked). In contrast, 
crosslinked scaffolds showed a large amount of gelatin retained within the scaffold mesh (Fig. 28 
A, Composite crosslinked, red). Gelatin deposition was also evenly distributed within the fiber 
mesh, suggesting excellent integration between gelatin and PCL fibers. As a control, mGLT 
solution was cast atop PCL scaffold, resulting in a distinct boundary between gelatin hydrogel 
and PCL that suggested the separation of two scaffold formats (Fig. 29).     
 Scaffolds were dried in an oven and weighed before and after gentle washing in PBS for 
1 day at 37 °C to estimate the gelatin loss (Fig. 28 B, p < 0.01). After washing, non-crosslinked 
scaffolds lost one third of their initial weight (32.87% ± 3.89, n=5), whereas crosslinked 
scaffolds lost only 16% (15.89% ± 3.50, n=5). This finding is consistent with the gelatin content 
data estimated by hydroxyproline assay (Fig. 28 C, p < 0.01): crosslinked scaffold retained half 
of its initial gelatin content (44.53% ± 1.58, n=4), while non-crosslink scaffold preserved less 
than 3%. (2.93% ± 0.46, n=4). We then analyzed the impact of crosslinking on the mechanical 
strength of scaffolds, and found a 16.0% reduction in maximum load of non-crosslinked material 
after washing. In contrast, crosslinked scaffold demonstrated consistent maximum load with no 




Figure 28. Examination of gelatin retention. (A) Picrosirius red staining showed that non-crosslinked 
scaffolds lost most gelatin after washing (Composite non-crosslinked), whereas photo-crosslinked scaffolds retained 
a portion of incorporated gelatin within the scaffold mesh (Composite crosslinked, red). (B) Non-crosslinked 
scaffolds showed significantly higher weight loss compared with crosslinked scaffolds. (C) Difference in gelatin 
retention between crosslinked and non-crosslinked scaffolds was quantified by hydroxyproline assay. (D) 
Mechanical testing of crosslinked scaffolds demonstrated equivalent maximum load to that of dry composite 
scaffolds, while non-crosslinked scaffolds showed ~16% reduction after washing. *, p<0.05; **, p<0.01; n=4 
 
Figure 29. Picrosirius red staining of scaffolds. Unlike the crosslinked composite scaffold (upper), mGLT 
solution cast atop PCL scaffold aggregated on the surface of PCL fibers after crosslinking (lower). 
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4.4.3 Multilayered construct created by photocrosslinking 
The crosslinkable nature of composite scaffold combined with the excellent integration 
between gelatin deposition and fibrous PCL suggests the possibility of preparing multilayered 
constructs by stacking and photocrosslinking individual scaffold layers. To test the feasibility of 
this approach, two scaffold sheets were partially overlapped with or without subsequent 
photocrosslinking (Fig. 30 A). Some of the non-crosslink scaffold pairs no longer adhered to 
each other after washing, whereas all crosslinked scaffold layers remain intact (Fig. 30 B). After 
washing in PBS at 37 °C, unseparated scaffold layers were subjected to uniaxial stretch. The 
load-displacement curve revealed markedly higher resistance to tension in the crosslinked 
scaffold pair, indicating that the stacked layers of sheets can bond with each other (Fig. 30 C). 
 
 Figure 30. Laminar integration of scaffold sheets. (A) Scaffold pairs were prepared by overlaying 1/3 the 
area of one scaffold sheet atop another and then photocrosslinked. (B) Without crosslinking, the scaffold pairs fell 
apart after washing, whereas crosslinked scaffold pairs remained intact. Blue lines suggested the boundary of 
overlapping regions. (C) Representative load-displacement curve of crosslinked scaffold pairs showed higher 
resistance to tension. n=6 
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To create multilayered constructs, 5 sheets of scaffold were wetted with photo-initiator 
solution, stacked and exposed to VL to crosslink adjacent scaffold layers (Fig. 31 A). After 7 
days of washing in PBS, a substantial difference in scaffold integrity was identified by 
picrosirius red staining (Fig. 31 B). Without crosslinking (left, CN), the scaffold layers did not 
adhere to each other. Sandwich constructs made from alternative layers of fibrous PCL and 
mGLT showed partial failure (center, PC), while crosslinked multilayer composite scaffolds 
remained fully integrated with negligible separation between layers (right, CC). Mechanical 
testing showed significantly higher tensile strength of crosslinked scaffolds than non-crosslinked 
scaffolds (Fig. 31 C, CC vs. CN, p<0.05, n=6), while the integration between layers exerted little 
impact on overall tensile strength (Fig. 31 C, PC vs. CC, n=6). 
 
Figure 31. Preparation and characterization of multilayer construct. (A) Five scaffold sheets were wetted, 
stacked and exposed to VL to crosslink adjacent scaffold layers. (B) Picrosirius red staining showed pronounced 
difference in scaffold integrity after washing among the three groups: stacked composite scaffold without 
crosslinking (CN, left), sandwich construct made from alternative layers of fibrous PCL and mGLT (PC, center), 
and crosslinked composite scaffold (CC, right). (C) Higher tensile strength was found in crosslinked scaffolds than 
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in non-crosslinked scaffolds (CC vs. CN), while the integration between fibrous scaffolds had little impact on 
overall tensile strength (CC vs. PC). *, p<0.05; n=6 
4.4.4 Cell incorporation and activity in multilayered construct 
hASCs were impregnated into the crosslinked PCL/mGLT sandwich constructs (PC) or 
crosslinked composite constructs (CC) to generate a cell-laden graft. After 7 days of culture, 
EthD-1 staining showed that most hASCs were localized in the interstitial space between 
adjacent layers (Fig. 32 A; red). Crosslinked composite constructs again showed better structural 
integrity than that of sandwich constructs (Fig. 32 A; dark red). Moreover, hASCs impregnated 
in composite scaffold displayed significantly higher metabolic activity (Fig. 32 B), while total 
cell number, reflected by the dsDNA content, remained comparable between two groups (Fig. 32 
C). These two findings suggest that constructs made from composite scaffolds promote cell 
metabolism but not proliferation.  
 
 Figure 32. Analysis of cell distribution and metabolic activity in multilayer constructs. (A) Ethidium 
homodimer-1 (EthD-1, red) staining indicated that most cells were localized between two adjacent layers. 
Crosslinked composite constructs (CC) demonstrated evidently higher structural integrity than sandwich constructs 
(PC). (B) MTS assay revealed significantly higher metabolic activity of cells impregnated in composite scaffold 
(CC), whereas (C) the total cell number  remained comparable to that of sandwich constructs (PC). *, p<0.05; n=8 
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4.4.5 Characterization of tendon phenotype induced by aligned multilayered constructs 
To create tendon-mimicking constructs, aligned composite scaffolds were prepared and 
anisotropy confirmed by SEM (Fig. 33 A) and mechanical testing (Fig. 33 C, 0.12 ± 0.01 vs. 2.51 
± 1.33 MPa). F-actin fluorescent staining showed that impregnated hASCs adopted elongated 
morphology in the direction of fibers (Fig. 33 B; green, F-actin; blue, nuclei). For tendon cell 
lineage commitment, hASCs were treated with 10 ng/ml TGF-β3 for 7 days. Real-time PCR 
assay showed pronounced upregulation of tendon markers SCX and TNC (Fig. 33 D), indicating 
that encapsulated cells remained responsive to soluble tenogenic factors, and that the construct 
possessed sufficient porosity for cells to receive exogenous biochemical cues. 
 
 Figure 33. Tendon-like features of cell-impregnated multilayer constructs. (A) Fiber alignment observed 
by SEM. (B) Anisotropy in tensile strength were measured by mechanical testing along two directions (Longi. vs. 
Cross). (C) Elongated morphology of hASCs aligned in the direction of fibers (green, F-actin; blue, nuclei). (D) 
Significant upregulation of tendon markers scleraxis (SCX) and tenascin C (TNC) upon treatment with exogenous 
tenogenic factor TGF-β3 were measured by real-time PCR analysis. 
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4.5 DISCUSSION 
Scaffolds are of critical importance in the context of tissue engineering, serving to 
provide a physical substrate that can recapitulate the in vivo milieu of healthy tissues and thus 
orchestrate the activity of therapeutic cells in a tissue-specific fashion [219]. In terms of tendon 
tissue engineering, a number of scaffold designs have been developed to reproduce one or 
multiple structural/compositional characteristics of tendon tissues, among which aligned, 
electrospun fibrous scaffolds and the 3D hydrogels have been frequently implemented in 
preclinical models due to their possession of respective topographical cues and native 
biochemical cues to seeded therapeutic cells [104, 107, 183, 220]. Therefore, a composite 
scaffold consisting of fibrous scaffold sheets and hydrogel is a potentially promising approach 
for the mimicry of physical and biological features in combine of tendon tissue. 
To achieve this goal, we firstly prepared PCL/mGLT composite scaffolds by dual 
electrospinning. Upon VL irradiation, the free radicals generated from the photo-initiator 
resulted in crosslinking via methacrylate on the gelatin backbone [221], thereby generating a 
hydrogel network within the PCL fiber mesh. We chose gelatin rather than collagen as the 
bioactive building block of the construct for two reasons: (1) as a product of denatured collagen 
[222], gelatin possesses a portion of the amino acid sequence and bioactive motifs of the parent 
collagen and is consequently chemically similar to native collagen chains; and (2) gelatin is far 
less costly compared to purified collagen (~25 USD/100 g vs. 650 USD/100 mg, pricing from 
Sigma-Aldrich) while more stable to organic solvent dissolution [223]. These features make 
gelatin suitable for industry-scale scaffold manufacturing.  
For electrospinning, PCL and mGLT were dissolved and extruded separately to create 
intercalated PCL and mGLT fibers so that the mechanical strength of the PCL scaffold mesh is 
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not compromised by the change in mGLT structure upon hydration. In contrast, electrospinning 
of a mixed solution of gelatin and PCL led to a collection of fibers comprised of alternating 
segments of gelatin and PCL, in which the dissolution of gelatin will presumably lead to fiber 
dissociation at gelatin regions and sequential loss of overall mechanical strength [224]. 
Concentrations of PCL and mGLT ranging from 10% to 22% were tested, and 18% PCL and 
20% mGLT were chosen based on the stability of the solution stream during electrospinning 
[225]. However, improvement in tensile strength is clearly needed if the scaffold is intended to 
be used to construct a clinical tendon graft (~550 MPa) [195]. Notably, although mGLT fibers 
rapidly dissolved upon wetting and therefore possibly increased the pore size of the scaffold, we 
did not observe any improved cell infiltration into the interior region of those crosslinked 
scaffolds (Fig. 34) [226]. The gelatin hydrogel formed within the PCL fiber mesh may occupy 
the pores and impede cell migration. To address this potential issue, a peptide linker containing a 
matrix metalloproteinase (MMP)-sensitive motif might be incorporated to generate a more cell-






Figure 34. DAPI-stained cross-sections of ASC-seeded scaffolds after one week of in vitro culture. 
Dissolution of gelatin without crosslinking increased scaffold porosity and therefore improved cell infiltration 
(Composite non-crosslink) compared to cells seeded on PCL scaffold. However, retention of gelatin via crosslinking 
appeared to impede ASC migration into the interior region of scaffold (Composite crosslink). Blue, nuclei; scaffolds 
were outlined by white dash lines. 
 
In addition to presenting multiple environmental cues, multi-layering of fibrous scaffold 
sheets can be employed to reconstitute the 3D architecture of a native tissue [219]. To achieve 
this goal, the rapid, robust integration between scaffold layers and sufficient incorporation of 
therapeutic cells must be carefully balanced [229-231]. In the scaffold described here, the gelatin 
component was found evenly distributed throughout the depth of PCL mesh, and therefore 
enabled integration of multiple sheets along the z axis upon photocrosslinking. Moreover, the 
VL-based photocrosslinking technique employed in our study is biocompatible, as our previous 
study found less than 6% cell death [232]. By combining these two characteristics, we have 
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achieved a robust and instant integration of scaffold layers that is compatible with simultaneous, 
sufficient cell encapsulation. For future study, the composite scaffold is open to further 
modifications that aim at eliciting the tenogenesis of impregnated cells. For instance, heparin 
may be conjugated to the gelatin backbone to sequester and deliver exogenous tenogenic growth 
factors into the constructs [233]. Tendon tissue derived-ECM may also be incorporated into the 
hydrogel portion of the constructs to recapitulate the proteinaceous microenvironment of native 
tendon tissue [183]. Finally, we believe that the scaffold engineered in this study as a building 
block for multilayer constructs should have applications beyond tendon tissue engineering in the 
fabrication of tissue grafts that contain both a fibrous component and a hydrogel portion 
4.6 CONCLUSION 
In this study, we developed a novel composite scaffold consisting of fibrous PCL and 
methacrylated gelatin (mGLT) interspersed by dual-electrospinning. The crosslinkable nature of 
the composite scaffold, together with the excellent integration of the gelatin within the PCL 
mesh, allowed the creation of a multilayered construct as a tendon graft through photo-
crosslinking of stacked scaffold sheets. Human ASCs were impregnated into the scaffold to 
generate a cell-laden construct and were seen to align along the orientation of fibers. Seeded cells 
adopted tendon cell phenotype upon treatment with TGF-β3. These findings provide information 
for the development of more advanced tendon grafts that can mimic both structural and cellular 




5.0 DISCUSSION, ADDITIONAL FINDINGS, AND FUTURE PERSPECTIVE 
This dissertation study revealed the tenogenic effect of tendon derived extracellular 
matrix (tECM) on human adipose stem cells (hASCs) cultured under various conditions. In a 3-
dimensional (3D) collagen scaffold under uniaxial tension, the presence of tECM improved 
tenogenic differentiation while suppressed the osteogenic differentiation of hASCs induced by 
uniaxial tension and enhanced scaffold mechanical strength, accompanied by reduced expression 
and activity of matrix metalloproteinases (MMPs). Furthermore, tECM enhanced the 
proliferation and TGF-β-induced tenogenesis of ASCs in 2D culture, and modulated matrix 
deposition and organization by ASCs seeded in 3D fibrous scaffolds. We also reported the 
development of a novel composite fibrous scaffold as a tendon graft fabricated by co-
electrospinning of poly-ε-caprolactone (PCL) and methacrylated gelatin (mGLT), which allowed 
the encapsulation of ASCs within the scaffold upon visible light induced gelatin photo-
crosslinking, as well as the formation of crosslinked multilayer constructs. This scaffold design 
can serve as an effective reservoir of tECM and tenogenic growth factors to recapitulate the 
structural and biochemical characteristics of native tendon tissue. In addition to all the findings 
presented, we propose the following future studies to address the limitations of current study and 
obtain more insights into the research subject. 
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5.1 ADIPOSE STEM CELL ISOLATION AND CHARACTERIZATION 
5.1.1 hASC isolation 
Adipose tissue is composed mainly of fat cells, which constitute more than 90% of the 
cellular component, and a stromal vascular fraction (SVF) consisting of a mixture of cell 
phenotypes, including ASCs [83]. A number of earlier studies have suggested correlation 
between the characteristics of ASCs and their site of harvest. For instance, ASCs harvested from 
superficial abdominal regions demonstrate greater resistance to apoptosis than those isolated 
from the upper arm, medial thigh and deep abdominal depots [234]. Likewise, the density of 
stem cells reserved within adipose tissue is also a function of anatomical location, tissue type, 
and animal species. For example, for white adipose tissue, ASC yields are higher in 
subcutaneous depots compared with visceral fat [235]. Of relevance to the subject of this 
dissertation research, tendon tissue engineering, the ASC population isolated from infrapatellar 
fat pad (IPFP) is perhaps particularly worthy of studying in the future as a potential cell source, 
for previous studies have shown considerable MSC activity from IPFP-derived cells [236], 
which have been speculated to be involved in the healing of patellar tendons [237]. However, 
current studies of IPFP ASCs are primarily restricted to their chondrogenic capacity, while their 
tenogenic potential remains largely unknown. For instance, cells derived from the IPFP were 
found to possess undiminished chondrogenic potential (comparable to control BMSCs) even 
isolated from osteoarthritic donors, or after a significant number of population doublings in vitro 
[238, 239]. Of equal importance is that the IPFP is an intracapsular, extrasynovial structure 
within the knee that lies directly posterior to the patellar tendon. The close proximity between 
resident cells of IPFP and surrounding patellar tendon tissues implies possible interaction 
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between IPFP ASCs and tendon ECM (Fig. 35). It is therefore reasonable to hypothesize that 
IPFP ASCs will respond rapidly to tECM treatment as well as other tenogenic factors by 
undergoing tenogenesis. This assumption is indirectly evidenced by the finding that IPFP ASCs 
expanded on ECM deposited by synovium-derived stem cells (SDSCs) displayed intensive 
chondrogenic markers, on the basis of histology [240].       
 
Figure 35. The location of the infrapatellar fat pad in knee joint (orange). 
5.1.2 hASC characterization 
The phenotypic characterization of ASCs is at an early stage. To date, a precise definition 
of the ASC phenotype is lacking, compromising a clear distinction between these cells and 
fibroblasts. Therefore, a combination of multiple cluster of differentiation (CD) markers are often 
targeted to distinguish ASCs (CD31-, CD34+/-, CD45-, CD90+, CD105- and CD146-) from 
other heterogeneous cell populations found in freshly isolated SVF, including endothelial cells 
(CD31+, CD34+/-, CD45-, CD90+, CD105-, and CD146+), vascular smooth muscle cells 
(CD31-, CD34+/-, CD45-, CD90+, CD105-, and CD146+), and hematopoietic stem cells 
(CD45+) [185]. ASCs share many cell surface markers with pericytes and bone marrow MSCs. 
Besides those listed above, pericyte markers are expressed by ASCs, including smooth muscle β-
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actin, platelet-derived growth factor (PDGF) receptor-β, and neuro-glial proteoglycan 2, while 
the markers shared by ASCs and bone marrow MSCs include CD13, CD29, CD44, CD58, and 
CD166 [241]. In addition to similarity of CD marker profile among these cell types, culture 
conditions may also markedly affect ASC gene expression, such as culture medium, mechano-
physiological environment, and degree of oxygenation [148]. Taken together, CD marker 
profiling must be coupled with other characterization approaches to accurately identify the ASC 
population from heterogeneous SVF preparations based on proliferation and multi-lineage 
differentiation potentials.  
ASCs possess the potential to differentiate into a variety of cell lineages [147]. As far as 
the regeneration of mesodermal tissues is concerned, ASCs can undergo adipogenic, osteogenic, 
chondrogenic, and myogenic differentiation [149, 186, 242, 243]. Compared to BMSCs and 
tendon-derived stem/progenitor cells (TSPCs), ASCs displayed reduced chondrogenic potential 
under standard differentiation conditions driven by TGF-β, which may be improved by co-
treatment with BMP-6 to restore the functions of TGF-β receptor I [244].  
5.2 TENOGENIC DIFFERENTIATION OF ADIPOSE STEM CELLS  
As noted in INTRODUCTION, the tendon cell lineage commitment of ASCs remains 
inconclusive. To date, an effective and putative protocol is lacking for tenogenesis of ASCs 
across species, underscoring the need to optimize the type and dose of inductive factor for 
tenogenesis through a case-dependent fashion.  
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5.2.1 Induction of ASC tenogensis via growth factor treatment 
We tested the tenogenic effect of several growth factors on hASCs, including bFGF, 
GDF-5 (BMP-14), GDF-7 (BMP-12), and TGF-β3, due to their known active involvement in 
either tendon morphogenesis or physiological tendon healing. For instance, members of the 
transforming growth factor-β (TGFβ) superfamily are involved in regulating tendon 
development, as has been found in various species. TGFβ-2/3 ligand and its receptors were 
detected throughout the tertiary bundles in the tendon midsubstance and endotenon during the 
intermediate stages of tendon development in the chick embryo [12]. Growth and differentiation 
factors (GDF), members of the bone morphogenetic protein (BMP) family, are additional 
regulators of tendon development and healing. Subcutaneous implantation of GDF-5, 6, and 7 
leads to the formation of neotendon-like connective tissue in rats [245]. Mice deficient in GDF-5 
demonstrate inferior matrix composition and mechanical strength in their Achilles tendons [246]. 
From a regeneration perspective, rat tendon injury model exhibited a biphasic pattern in which 
TGF-β1 expression was highest in the early phases of healing and gradually decreased thereafter, 
when TGF-β3 was upregulated [51]. Similarly, tendons subjected to transection and repair 
exhibited an increased signal for bFGF mRNA in both resident tenocytes and in the fibroblasts 
and inflammatory cells located in the tendon sheath [64]. Besides, bFGF significantly accelerated 
wound closure of a rat patellar tendon defect in vitro [247].  
To explore the possible dose effect of growth factors on tenogenesis of hASCs, cells were 
cultured with each type of growth factor at a range of serial concentrations for 7 days and then 
analyzed. Real-time PCR analysis suggested that GDF-5 or GDF-7 treatment was not able to 
significantly upregulate the expression of SCX or TNC regardless of the amount used in the test. 
No evident dose effect on tenogenesis of ASCs was found for these two growth factors (Fig. 36). 
 112 
In contrast, bFGF and TGF-β3 were found to be capable of inducing tenogenic differentiation to 
distinct extents (Fig. 36). When treated with 1 ng/ml of bFGF, the expression level of SCX and 
TNC was increased by 2.02- and 2.79-fold, respectively. Nevertheless, higher concentrations of 
bFGF did not result in any pronounced tendon lineage commitment. In comparison, tendon 
marker expression levels were markedly increased by TGF-β3 and plateaued when exposed to 10 
ng/ml TGF-β3, in which SCX and TNC levels were 21.65- and 3.89 -fold higher than the 
untreated control. From these initial findings, TGF-β3 at 10 ng/ml was selected as the primary 
tenogenic factor for this dissertation study. To further characterize the regulation of tendon 
lineage commitment, the combined effects and specific spatiotemporal coordination of the 
activities of multiple growth factors on ASC tenogenesis must be carefully studied.  
 
Figure 36. Dose effect of growth factors on the tenogenesis of hASCs analyzed by real time PCR analysis. 
bFGF and TGF-β3 treatment was able to significantly upregulate SCX and TNC level. *, p < 0.05; **, p < 0.01; n = 
4 
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5.2.2 Induction of ASC tenogensis via tensioned 3D culture 
While the most common approach to direct MSCs to differentiate into a specific lineage 
in vitro is through growth factor stimulation, tenogenesis of MSCs can also be induced through 
uniaxial tension in 3D culture [87, 126, 142]. In this study, we used the Flexcell Strain Unit with 
the Tissue Train culture plates to generate 3D cylindrical constructs under tension, and 
confirmed that hASCs underwent tenogenesis in response to static mechanical stimuli. Collagen 
type I (Col I) gel was used as the scaffold material for many reasons. First, Col I is the primary 
structural component of tendon tissue and is thus widely used in tendon tissue engineering. 
Second, collagen hydrogel is contractible when interacting with cells, and can thereby create 
tension without the need to apply exogenous force. Furthermore, compared to synthetic polymer 
mesh, tensioned collagen hydrogel is soft enough to reflect cell-mediated matrix remodeling by 
changes in macroscopic shape and strength.  
A promising future prospect based on this work is the application of dynamic/cyclic 
stretch to the construct besides static tension to simulate the postnatal loading of tendon during 
motions. In this regard, cyclic uniaxial tension has been found to promote greater tenogenic 
effects, and that dynamic stretching is required to maintain expression of SCX over time [126]. 
However, tenogenic effect of dynamic loading on encapsulated cells in the presence of tECM is 
yet to be explored. Likewise, dynamic loading may be combined with other known pro-
tenogenesis factors, such as growth factor treatment or scaffold alignment, to recapitulate the 
pattern of tendon morphogenesis precisely in vitro.  
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5.3 THE BIOACTIVITY OF TENDON EXTRACELLULAR MATRIX 
Extracellular matrix (ECM), a network of proteins secreted by cells that provides 
structural and biochemical support to the surrounding cells, also plays important roles in 
regulating cell behavior. Tissue-derived ECMs have been generally found to induce 
corresponding differentiation of MSCs toward the phenotype of cells in the tissue from which the 
ECM is derived, and are therefore considered as attractive candidate biomaterials to support stem 
cell-based tissue-specific regeneration. [38, 122, 123, 153, 154]. These findings represent the 
principal rationale of the core hypothesis of this dissertation study: Tendon ECM has a positive 
influence on the proliferation and tenogenic differentiation of hASCs.  
To test our hypothesis, we used the chaotropic reagent, urea, to disrupt lipid-lipid, lipid-
protein, and protein-protein interactions in the tendon ECM network without enzymatic digestion 
of ECM components [156]. By using this approach, we succeeded in obtaining a water soluble 
extract of tendon ECM rich in non-collagenous proteins that would have otherwise been 
significantly degraded if enzyme treatment was used to dissociate the tissue. We then examined 
the effect of biochemical components of tECM on ASCs maintained in standard 2D culture. 
Unlike other studies that aimed at exploring the bioactivity of ECM, the tECM in our study was 
used as a medium supplement rather than as a coating of the culture substrate [144, 248]; for 
immediate cell binding to a rigid ECM substrate coating could affect cell shape and initial cell-
seeding density compared to interaction with soluble, free ECM. Our results showed that 
exposure to the soluble tECM significantly enhanced tenogenic activity of the ASCs, particularly 
in terms of the influence of mechanoactivation. Further exploration of the underlying mechanism 
of the bioactivity of tECM will require:  (1) determination of the effective composition of tECM, 
and (2) understanding the interaction between tECM and cells.  
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5.3.1 Determination of the functional composition of tendon ECM 
The quest for a comprehensive understanding of the molecular mechanisms of ECM 
regulation in cell activity has become a research hotspot in recent years via high throughput 
analytical approaches such as proteomics. Mass spectrometry (MS) based proteomic 
technologies, in particular, provide the opportunity for rapid and thorough analyses of ECM 
composition [249].  
In terms of the in-depth analysis of tECM, the samples can be enzymatically digested into 
peptides and then analyzed by tandem MS, the core technology used in ‘bottom-up’ proteomics 
that results in the fragmentation of peptide ions to provide structural information about the ions 
and subsequently enables the determination of their amino acid sequence. With the availability of 
completed genome sequences, protein sequence databases can be queried with MS data using 
database search tools to infer the identity of peptides, and thus their corresponding proteins 
present in the samples [250-252]. In fact, many proteomic studies have been conducted on 
healthy or diseased whole tendon tissues. For instance, tandem MS-based proteomics analysis 
comparing healing tendons to uninjured tendons revealed significant increases in proteins 
associated with inflammation, stress response, and matrix degradation [253]. Likewise, 
significant differences were found by tandem MS between male and female in components of the 
tendon proteome critical for response to mechanical loading and injury [254]. These studies have 
suggested the feasibility of using proteomic techniques to analyze the composition of tECM. 
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5.3.2 Understanding the interaction between tendon ECM and cells 
We found that tECM treatment on ASCs increased proliferation and TNC expression in 
the absence of other inductive cues. Expression of both TNC and SCX was further enhanced 
when treated concomitantly with TGF-β3. The enhancement of ASC tenogenesis by tECM 
combined with TGF-β3 treatment may be attributed to two possible events: (1) the tECM serves 
as a reservoir of signals distinct from TGF-β; or, not mutually exclusively, (2) the tECM exerts a 
regulatory effect on exogenous inductive cues. We believed that the latter assumption is more 
dominant, as exposure to tECM substantially increased Smad phosphorylation in response to 
exogenous TGF-β3 (Fig. 37). In addition, the content of TGF-β3 carried in tECM solution is 
negligible compared to the amount added into the medium (160 pg/ml vs. 10 ng/ml). We propose 
that particular research attention should be paid to the interaction between cell surface integrins 
and tECM as the initial step of an outside-in signal transduction (Fig. 38). In our view, integrin 
mediated cross talk between TGF-β signaling pathway and the tECM is a promising approach for 
future studies. Signal induction initiated by ECM-integrin interactions at focal adhesion sites 
may affect TGF-β signaling either through enzymatic action of protein complex recruited to the 
cytoplasmic domain of integrins or influence interaction with the actin cytoskeleton  [255]. We 
speculate that there is functional cross talk between integrin mediated signaling pathways and 




Figure 37. Western blot of phosphorylated Smad2 (P-SMAD2) and total SMAD2/3 revealed the kinetics of 
cell response to TGF-β3. Exposure to tECM increased SMAD2 phosphorylation. GAPDH is used as an endogenous 
control. n=3 
 
Figure 38. Real time PCR analysis revealed that blockade of tECM-integrin interaction with integrin 
antagonist (GRGDS) led to a drop in the expression level of tendon markers to the similar level as those in TGF-
β3+/tECM- group. *, p<0.05, compared with all other groups; n=6 
5.4 SCAFFOLD DEVELOPMENT FOR TENDON TISSUE ENGINEERING 
Properly differentiated cell population alone is not sufficient to address clinical 
challenges in tissue engineering based tendon repair. First of all, therapeutic cells need to be 
immobilized to the site of injury to function in a site-appropriate manner. Secondly, specific 
topographical characteristics along with other physical cues must be presented to the 
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microenvironment in order to induce and maintain the desired phenotype of the seeded cells. 
Lastly, seeded cells are not able to restore the mechanical strength of injured tendon tissue until 
adequate amounts of tissue specific ECM have been produced and deposited in a structurally 
relevant manner, and are therefore unable to prevent secondary rupture or reduction in tissue 
integrity during early rehabilitation stages. These concerns motivate in part the desire to develop 
bioactive/biocompatible scaffolds capable of bridging the gap between bench side study and 
clinical repair. 
In this dissertation research, two basic types of scaffold were studied: (1) hydrogel made 
of auto-assembled collagen macromolecules; and (2) electrospun polyester microfibrous mesh. 
The use of these scaffold culture models not only represented a platform for studying the 
bioactivity of tECM within tendon-mimicking physical microenvironment, but also allowed us to 
develop a novel, advanced tendon-like construct consisting of hydrogel and scaffold mesh 
composite. We propose here the following respective adjustments and improvements to address 
the limitations of the scaffold formats used and developed in this study. 
5.4.1 Possible improvements of hydrogel scaffold 
Although the study on collagenous hydrogel-based culture is fruitful, the current collagen 
hydrogel system is insufficient in a number of aspects. Firstly, we are concerned that a collagen-
rich microenvironment, possibly via biological feedback regulation, may influence the natural, 
early sequence of mesenchymal tenogenesis, since the natural process would necessarily arise 
prior to matrix saturation with collagen. Secondly, identification and detection of the deposition 
and organization of newly produced collagen fibrils is complicated by the abundant collagenous 
matrix. In this regard, constructs made of hyaluronic acid (HA) or fibrin are possibly better 
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alternative platforms if the aim is to track collagen fibril formation. Secondly, as noted in 
INTRODUCTION, the proper formation of covalent cross-links between adjacent collagen 
molecules deserves research attention in order to enhance collagen interconnectivity and 
subsequently reinforce the constructs if intended to use as a clinical graft. Characterization of 
crosslinking, e.g., activity of lysyl oxidase and quantitation of pyridinoline, would be helpful for 
this assessment.  
5.4.2 Possible improvements of fibrous scaffold 
Unlike hydrogels, the fibrous PCL scaffold is engineered to provide the necessary 
topographical characteristics and mechanical strength. However, we chose to use tECM as a 
medium supplement for cells seeded on PCL scaffold rather than as a coating material to pre-
treat the scaffold surface, for a rapid loss of protein coating was observed during incubation 
despite significant initial adsorption. Moreover, unlike collagen, PCL lacks the motifs and 
residues that mediate cell interaction, leading to unsatisfactory cell attachment rate and viability. 
Although medium supplementation of tECM is sufficient to rescue the absence of bioactivity of 
scaffolds in an ex vivo culture system, functional in vivo implant requires a scaffold that retains 
bioactive agents without large-scale diffusion. For this purpose, scaffold surface modification 
seems a promising approach to address the challenge. For instance, amino groups can be 
covalently introduced onto PCL scaffold surface by reacting 1,6-hexanediamine with the ester 
groups of PCL, known as aminolysis [256]. The added amino groups may be targeted to 
immobilize bioactive macromolecules contained in tECM on the aminolyzed PCL scaffold using 
bifunctional cross-linking agents [257]. In addition, the introduction of reactive amino groups 
enables covalent crosslinking between adjacent fibers, and therefore reinforces the mechanical 
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strength of scaffolds. Another prospective approach is to blend PCL polymer with biologically 
active materials prior to electrospinning [258-260]. However, denaturation of bioactive 
molecules in organic solvent is a serious concern [261]. Moreover, at present, the functional 
bioactive molecules that drive tendon regeneration remain unclear.  
5.4.3 Possible improvements for composite scaffold   
The fact that the cell-containing hydrogel reinforced by structural fibers exhibits an 
organization similar to that of native ECM motivated us to develop a composite construct 
consisting of both fibrous scaffold mesh and ECM hydrogel. When wetted and exposed to visible 
light (VL) irradiation, the free radicals generated from the photo-initiator crosslink methacrylate 
groups presented by gelatin molecules, thereby forming hydrogel within the network of PCL 
fibers to retain water and ECM proteins.   
Notably, although mGLT fibers rapidly dissolved upon wetting and therefore possibly 
increased the pore size of the scaffold, we did not observe any improved cell infiltration into the 
interior region of those crosslinked scaffolds [226]. The gelatin hydrogel formed within the PCL 
fiber mesh may occupy the pores and impede cell migration. In the future, to address this 
potential issue, a molecular linker containing an MMP-degradable peptide sequence might be 
used to generate a more cell-degradable hydrogel within a fibrous scaffold to improve cell 
infiltration [227, 228]. In fact, depending on the specific requirements, appropriate peptide 
sequences that correspond to specific MMPs may be adopted to generate specific bio-
responsiveness to the microproteolytic environment.  It should be point out that the construct we 
have prepared so far was made of no more than five layers of scaffold sheet to ensure the 
orthogonal penetration of light into the construct for sufficient crosslinking. Higher degree of 
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stacking may result in inadequate crosslinking in the center zone of the construct due to the 
accumulated opacity. To address such restriction on construct thickness, thermo-responsive or 
chemically initiated crosslinkers may be considered in order to overcome the limitation of light 
penetration. For future studies that aim at eliciting the tenogenesis of impregnated cells, the 
composite scaffold is open to further modifications. For instance, heparin can be conjugated to 
the gelatin backbone in order to sequester and subsequently deliver exogenous tenogenic growth 
factors into the constructs [233]. In a similar manner, the tECM can be incorporated into the 
hydrogel portion of the constructs during crosslinking to “reconstitute” the protein profile of 
native tendon tissue.   
5.5 CONCLUSIONS 
In conclusion, this dissertation research has demonstrated the bioactivity of a soluble 
fraction of tendon-derived extracellular matrix (tECM) on the proliferation and tenogenic 
differentiation of human adipose stem cell (hASC) cultured in 2D with TGF-β3 or within 3D 
scaffolds. Moreover, hASCs in tECM-containing 3D cultures demonstrated suppressed 
osteogenesis under tension and improved matrix deposition and organization on aligned fibrous 
scaffold. In addition, we developed a novel multilayered construct as a tendon graft through 
photo-crosslinking of stacked composite scaffold sheets, and demonstrated tendon cell 
phenotype of impregnated hASCs.  
We believe that these findings will have considerable utility in the field of tendon tissue 
engineering. As mesenchymal stem cells (MSCs) continue to be a research focus in tissue 
engineering, incorporating tendon specific ECM molecules into differentiation protocols 
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represents an alternative approach to achieve robust tenogenesis of ASCs to better exploit the 
their regenerative potential. Furthermore, the design attributes of the 3D scaffolds developed in 
this study are applicable not only to functional tendon tissue engineering, but also to reproducing 
structural and cellular characteristics of other native tissues. The scaffold design is open to 
further modifications to elicit the tissue-specific differentiation of impregnated cells. We believe 
that the successful, translational application of our findings is likely to improve patient outcomes 
















LIST OF ABBREVIATIONS 
Abbreviation Full term 
ASC adipose derived mesenchymal stem cell/adipose stem cell 
bFGF basic fibroblast growth factor 
BGC biglycan 
BM basal medium 
BMP bone morphogenetic protein 
BMSC bone marrow derived mesenchymal stem cell 
BSA bovine serum albumin 
CFU-F colony forming unit-fibroblast 
COL I collagen type I gene 
Col I collagen type I protein 
COL I A1 collagen type I α1 chain-encoding gene 
COMP collagen oligomeric matrix protein 
CTGF connective tissue growth factor 
DCR decorin 
DM differentiation medium 
DMF dimethylformamide 
ECM extracellular matrix 
FBS fetal bovine serum 




GDF growth differentiation factor 
GM growth medium 
hASC human adipose stem cell 
HBSS Hanks’ balanced salt solution 
HRP horseradish peroxidase 
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Abbreviation Full term 
IGF insulin-like growth factor 




mGLT methacrlyated gelatin 
MKX mohawk homeobox 
MMP matrix metalloproteinase 
MSC mesenchymal stem cell 
P/S penicillin/streptomycin 
PBS phosphate buffered saline 
PCL poly-ε-caprolactone 
PDGF platelet-derived growth factor 
PGA polyglycolic acid 
PLLA poly-L-lactic acid 
SCX scleraxis gene 
Scx scleraxis protein 
SDS sodium dodecyl sulfate 
SEM scanning electron microscopy 
SHH sonic hedgehog 
SIS small intestinal submucosa 
SLRP small leucine-rich proteoglycan 
SVF stromal vascular fraction 
TC tenocyte 
tECM soluble fraction of tendon ECM 
TFE 2,2,2-trifluoroethanol 
TGF-β transforming growth factor-β 
THF tetrahydrofuran 
TNC tenascin-C 
TNMD tenomodulin gene 
Tnmd tenomodulin protein 
TSPC tendon stem/progenitor cell 
UBM urinary bladder matrix 
VEGF vascular endothelial growth factor 
VL visible light 
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